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ABSTRACT 
Background: Dental fear and anxiety are common encounters in paediatric dentistry. 
Therefore, it is important to understand the causes and types of dental anxiety in order to 
implement the appropriate behaviour management strategies so that high quality dental care 
could be delivered and disruptive behaviour is minimised. Some dentally anxious 
individuals have reported that the provision of a form for sedation would facilitate their 
dental treatment. Therefore assessing the need for sedation would be beneficial. Aim: To 
assess the treatment outcomes of using inhalation sedation for comprehensive dental care 
within the hospital dental service by utilising a modified version of the Indicator of 
Sedation Need (IOSN) assessment tool. Materials and Methods: The present study was 
carried out in two phases: Retrospective Phase – A study of the treatment outcomes when 
using inhalation sedation for comprehensive dental care within the hospital dental service. 
Prospective Phase - A study investigating the outcomes of dental treatment of patients 
referred to the sedation unit at the LDI when the paediatric version of the indicator of 
sedation need (p-IOSN) was utilised. Results: Retrospective Phase: the records of 453 
patients (213 males and 240 females) were evaluated. Mean age was 10.30 (SD = 2.95) 
years. Treatment was completed successfully in 63.6% of the cases. Results revealed that 
age below 10 years was significantly associated with the outcome that “treatment 
abandoned in sedation unit and child referred to receive treatment under general anaesthesia 
(GA)”. No significant association was found between gender and treatment outcome. 
Prospective Phase: Forty patients (16 males and 24 females) of mean age 9.99 (SD = 3.14) 
years were followed up to ascertain treatment outcomes when the p-IOSN was used. Of the 
total of 40 children included in the prospective study, 20 (50%) scored 6 on p-IOSN. 
Treatment completion rate was 72.5%. Although major differences existed between age and 
treatment outcomes, they failed to achieve statistical significance. No significant 
association was found between gender and p-IOSN of any score with any treatment 
outcome. Conclusions: p-IOSN is a useful tool that can be utilised to predict child patients 
who would benefit from sedation for their dental treatment. However, the p-IOSN is still in 
the investigational stages and further research is required prior to its use on the clinical 
grounds.  
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1.0  LITERATURE REVIEW 
Reviewing the literature is an essential process to understand any subject. With the help 
and availability of various search engines and databases, the relevant published literature 
has been identified and evaluated in order to establish a reasonable knowledge about the 
use of conscious sedation for the dental treatment of anxious paediatric patients.  
Dental fear and anxiety are common problems in dentistry and particularly in paediatric 
dentistry  (Welbury et al., 2012). Therefore, it is important to understand the aetiology and 
pattern of the dental anxiety in order to employ the appropriate behaviour management 
technique(s) so that high quality dental care could be delivered and disruptive behaviour is 
eliminated (Chadwick, 2002). Some dentally anxious individuals have reported that the 
provision of sedation would facilitate their dental treatment (Girdler and Hill, 1998). 
Therefore assessing the need for sedation would be very beneficial. 
In the following sections of this chapter dental anxiety, behaviour management techniques, 
methods to assess the need for sedation and the aim of the present study were further 
discussed.   
 
1.1  DENTAL ANXIETY 
Fear of dental treatment and dental anxiety are prevalent in children. They have negative 
impact on their quality of life and on the quality of the dental treatment they could receive 
both in terms of the nature of the dental treatment that is likely to be performed and the 
limiting of attendance for treatment (Newton et al., 2012). In the literature, the prevalence 
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of dental fear ranged from 5-20% with a mean prevalence of 11% (Themessl‐Huber et al., 
2010). According to Klingberg and Broberg (2007) anxiety is a multi-dimensional concept 
that consists of somatic, cognitive, and emotional elements, whereas dental fear is a normal 
emotional reaction to one or more specific frightening stimuli in the dental setting. 
Therefore, dental anxiety represents a state of apprehension that something related to the 
dental treatment will be dreadful, and it is coupled with a feeling of losing control. 
Whereas, dental phobia represents a severe type of dental anxiety and is characterised by 
marked and persistent anxiety in relation either to clearly discernible situations or objects. 
Based on the Diagnostic and Statistical Manual of Mental Disorders (DSM–IV) published 
by the American Psychiatric Association, the criteria for a diagnosis of a speciﬁc phobia are 
(American Psychiatric Association, 1994): 
 Unreasonable and excessive marked fear that is persistent. 
 Exposure to the fearful stimuli almost invariably provokes an immediate anxiety 
response. 
 The person recognises that the fear is excessive or unreasonable (this is probably 
absent in children). 
 The phobic situation is avoided or else endured with extreme nervousness or 
distress.  
Therefore, for a diagnosis of dental phobia it must result either in avoidance of required 
dental treatment altogether or tolerating treatment only with dread and in an adjusted 
treatment situation (e.g. specialised paediatric dentistry). It is important here to note that the 
terms dental fear, dental anxiety and dental phobia are used interchangeably within the 
dental literature (Klingberg and Broberg, 2007). 
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1.1.1  Aetiological Factors of Dental Fear and Anxiety 
Children’s phobia is believed to be multi-factorial and multi-dimensional. It has a complex 
aetiology involving genetic, constitutional and environmental factors (King et al., 1997). In 
this scope, Rachman has proposed an influential three pathways theory of phobia onset 
(Rachman, 1977). According to this theory, phobias are acquired through direct 
conditioning, vicarious conditioning or transmission of information and instructions. The 
three pathways are: 
 Direct conditioning (Direct Pathway): refers to the association between an 
unconditioned stimulus and a neutral stimulus. In the dental situation this means 
that a bad experience in one of the dental visits could cause a child to associate the 
dental situation in general with bad experience leading to aversive feelings and fear, 
and potentially avoidance of the situation. Children who have had negative 
experiences associated with medical treatment may be more anxious about dental 
treatment (Wright et al., 1973a). Similarly, fear sustained from previous unhappy 
dental visits has also been related to poor behaviour and fear at subsequent visits 
(Johnson and Baldwin Jr, 1968, McTigue, 1984). Milsom and colleagues believed 
that direct conditioning is the strongest predictor of child dental anxiety status. They 
have found that dental anxiety in children was closely related to traumatic treatment 
interventions (extraction), symptomatic, irregular attendance pattern, and having a 
dentally anxious parent. Therefore, they have recommended that dentists adopt a 
wait and watch approach rather than extraction in the very young children or 
children who are already dentally anxious (Milsom et al., 2003). 
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 Vicarious conditioning (Indirect Pathway): it implies that children’s fear could be 
acquired by observing significant others (e.g. parents, peers and siblings) reacting 
fearfully to a stimulus (emotional contagion hypothesis). A direct relationship 
between maternal anxiety and difficulties in child patient management at all ages 
has been reported by many studies (Corkey and Freeman, 1994, Freeman, 1999). A 
negative behaviour exhibited by a child patient during their first dental visit was 
positively associated with increased anxiety of their mother (Johnson and Baldwin 
Jr, 1968, Koenigsberg and Johnson, 1975). This relationship was more evident in 
children less than four years of age (Wright and Alpern, 1971, Wright et al., 1973b).  
 Transmission of information (Indirect Pathway): this indirect pathway refers to 
negative information about stimuli provided by significant others, books or media 
(Rachman, 1977). Several studies on common childhood fear provided support for 
the role of negative information, by asking children retrospectively about their 
experiences in the development of anxiety (King et al., 1998, Muris et al., 1997). 
Several other determinant factors have been associated with dental fear and phobia. Results 
on gender differences in relation to dental fear are controversial. Some studies have found 
no gender differences in children’s and adolescent’s dental fear (Locker et al., 2001, 
Majstorovic et al., 2003, Muris et al., 2005). However, several studies reported that girls are 
more dentally anxious than boys (Klingberg and Broberg, 2007, Majstorovic and 
Veerkamp, 2004). These results seem to differ according to the age of the children. In 
younger age groups, no significant gender effect has been found. On the other hand, more 
dental fear has been found in adolescent girls than in boys of the same age (Holst et al., 
1988, Neverlien, 1994). In a longitudinal study conducted by Murray and co-workers in 
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1989, it was found that self-efficacy, fear of death, and the number of dentists visited were 
the predictors of dental anxiety for boys. For girls, dental anxiety three years before, peer 
ratings and medical fear were found to be predictors of dental anxiety (Murray et al., 1989). 
It has been suggested that boys with dental anxiety may be more responsive to stress to 
their environment, while girl’s dental anxiety could be more internally mediated (Liddell, 
1990). These results suggest that dental fear and the factors associated with it differ with 
gender. 
Both dental fear and phobia are more common in young children, reflecting the influence of 
child’s psychological development on his or her ability to cope with dental treatment. A 
younger child may experience and understand the dental situation differently than an older 
child. One major reason for this is that the process of understanding and having the 
motivation to comply with dental treatment differs depending on the psychological 
development. The latter also depends on the communication skills of the dental team 
(Klingberg and Broberg, 2007). In a study constructed on 2,865 Dutch children aged 4-11 
years old, they confirmed that the highest level of dental anxiety was at age 4 years and 
overall decrease in dental anxiety occurred as children became older. In different age 
groups dental anxiety seems to be related to different aspects of dentistry, indicating the 
causes shift from simple initial stimuli to more complex events (Majstorovic and 
Veerkamp, 2005). 
A study by Fayle and Tahmassebi (2003) has suggested that there are more factors that 
could contribute to the development of dental anxiety. One of which is the dentist’s 
manner. A dentist with calm, caring and empathetic approach is more likely to manage an 
anxious child with success. Moreover, physical and eye contact can reinforce positive 
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behaviour and enable communication while criticism and tease are ineffective and result in 
diminished confidence and increased anxiety. Another factor is the intellectual capacity of 
the child. Children with communication or learning difficulties (e.g. mental retardation or 
impaired hearing or vision) may be more likely to show anxiety-related behaviour in the 
dental setting (Fayle and Tahmassebi, 2003).     
 
1.1.2  Evaluation of Dental Phobia and Behaviour Classification 
Different types of measures have been developed aiming to assess dental fear and anxiety 
in children and classify their behaviour in the dental operatory. The most widely used 
measures are the following: 
 Behaviour rating scores where the dentist or another member of the dental team 
observes the child’s behaviour during the treatment and then record a “score” for it. 
 Anxiety self-reports completed by the child or the parent. 
 
1.1.2.1  Behaviour rating scores 
The knowledge of these rating scores is beneficial in different ways. It can assist in 
directing the management technique as well as provide a means for systematically 
recording behaviours. These rating scores can also be used in different research projects 
(Welbury et al., 2012). 
1.1.2.1.1  Frankl behaviour rating scale 
This rating system divides observed behaviour into four categories, ranging from definitely 
positive to definitely negative. It is summarised in Table 1.1 (Frankl et al., 1962).  
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Table 1.1 Frankl Behaviour Rating Scale 
Rank Symbol Description 
Definitely 
negative 
- - 
 Refusal of treatment 
 crying forcefully 
 fearful  
 any other overt evidence of extreme negativism  
Negative - 
 Reluctant to accept treatment 
 Uncooperativeness 
 Some evidence of negative attitude but not 
pronounced 
Positive + 
 Acceptance of treatment 
 Cautious behaviour at times with reservation 
 Willingness to comply and cooperatively follows 
dentist’s directions 
Definitely 
positive 
++ 
 Good rapport with the dentist 
 Interest in the dental procedures 
 Laughter and enjoyment 
  
Frankl behaviour rating score is the most frequently used scale both in research and clinical 
grounds because of its ease of use and brevity. However, a limitation of this scale is that it 
does not provide sufficient clinical information regarding the uncooperative behaviour of 
the child. For example, if the child is judged as “negative” this could be interpreted as that 
the child was uncooperative throughout the procedure while this was recorded because the 
child was tearful when local anaesthesia was being delivered. Therefore, recording  
“-, tearful with LA” would be a better description of the clinical situation (Dean et al., 
2010). 
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1.1.2.1.2  Houpt rating score 
Houpt rating score is another tool to evaluate children’s behaviour during a dental visit 
(Lourenço-Matharu et al., 2012). Nevertheless, it is less often used than Frankl’s score. 
Description of Houpt rating score is presented in Table 1.2. 
Table 1.2 Houpt Rating Score 
Score Description  Treatment Result 
1 No treatment rendered Aborted 
2 Treatment interrupted; only partial treatment was 
completed 
Poor 
3 Treatment interrupted but eventually completed Fair 
4 Difficult but all treatment was performed Good 
5 Some limited crying or movement Very Good 
6 No Crying or movement  Excellent 
 
1.1.2.2  Anxiety self-reports 
1.1.2.2.1  Corah`s Dental Anxiety Survey (CDAS) 
This is a four-item measure developed in 1969. It assesses patients’ reaction to four 
different dental treatment situations: before attending the dental surgery, waiting in the 
dental operatory, sitting in the dental chair and undergoing treatment. Each question has 
five pre-structured answers evaluated on a scale from one to five; one indicates no anxiety 
whereas five indicates the maximum level of anxiety. Therefore, CDAS score ranges from 
4 (no anxiety) to 20 (extreme high anxiety). Anxiety using CDAS is rated as follows 
(Corah, 1969): 
 9-12: moderate anxiety but have specific stressors that should be discussed and 
managed 
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 13-14: high anxiety 
 15-20: severe anxiety 
CDAS is widely used in research for assessing dental anxiety in adults across the world. It 
has a high level of reliability and predictive value. However, it has been criticised for 
exhibiting a range of scores too narrow to be used effectively in clinical studies. Yet, it is 
efficient in the clinical setting as it can be completed in less than five minutes (Guinot et 
al., 2011).  
 
1.1.2.2.2  Modified Dental Anxiety Survey (MDAS) 
Based on the fact that injection is a major cause of anxiety for many individuals, CDAS has 
been modified by adding a fifth question concerning local anaesthetic. The answer options 
were rephrased and modified as well to reflect anxiety in a more clear order. MDAS has 
become the most frequently used dental anxiety questionnaire in the United Kingdom. The 
total score is the sum of the all 5 items which ranges from 5 to 25. Nineteen and above is 
the cut-off value that indicates a high level of anxiety (Humphris et al., 1995).  
 
1.1.2.2.3  Venham Picture Scale (VPS) 
VPS has been developed in 1977 and consists of eight pairs of pictures (Sonnenberg and 
Venham, 1977). Each pair consists of a child in a non-fearful pose and in a fearful pose and 
for each pair, the child is asked to choose the picture which more accurately reflects their 
feeling at the time. The final score is the sum of the number of times the child selects the 
high-fear stimulus (the minimum score is zero whereas the maximum is eight). VPS has 
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shown a strong test-retest reliability and internal consistence (0.70-0.84) (Venham and 
Gaulin-Kremer, 1979). VPS has shown many advantages when used in research, it is 
simple, quick to use and suitable for use with children 2-8 years old (Foster and Park, 
2012). Even children with limited verbal and intellectual ability have used it successfully. 
However, VPS does have some limitations (Buchanan and Niven, 2002). It has failed to 
differentiate between anxious and non-anxious children because no parameters were set to 
indicate high levels of anxiety. In addition, the figures on the card are all male which might 
present a problem when the young patient is a girl. Moreover, for teenagers some figures 
are ambiguous in what they are portraying (Aartman et al., 1997). 
 
1.1.2.2.4  Facial Image Scale (FIS) 
FIS has a row of five faces ranging from very happy to very unhappy thus making the 
choice easier for very young children. Children are asked to point at which face they felt 
most like at the moment. The scale is scored by giving a value of one to the most positive 
affect face and five to the most negative affect face. The scale has shown good validity in 
research. FIS has advantages over questionnaires in that it is quicker and easier to be used 
in clinical situations, takes a very short time, more suitable for very young children (3 years 
old) who lack the cognitive ability to understand and complete questionnaire and gives an 
immediate indication about child anxiety as well as provide interesting results regarding 
prevalence of child dental anxiety (Buchanan and Niven, 2002). 
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1.1.2.2.5  Smiley Faces Program (SFP) 
SFP is a four item computerised scale using faces as a response set to assess dental anxiety 
in children. The child will select from a range of seven facial expressions indicating how 
they feel. It is based on the MDAS and involves four questions relevant to a child`s 
experience in the dental practice environment (having dental treatment the following day, 
sitting in the waiting room, having injection and a tooth drilled). The SFP has a number of 
benefits. First, it is short in length and in turn takes a short time to complete. Second, all the 
items included are relevant to most children`s dental experiences. Third, the computer 
graphics help the child to engage with the dental anxiety scale. Children have found these 
graphics enjoyable and preferred them over the pen and paper questionnaire. Fourth, it 
identifies children who are anxious of a particular procedure. Finally, it has the advantage 
of facilitating data collection and standardising assessment. However, this scale could be 
too complicated for children younger than 6 years and children with learning difficulties to 
complete. Moreover, access for computer equipment is needed. The scale demonstrated 
good reliability (Buchanan, 2005). The SFP was revised (SPF-R) by Buchanan to include a 
fifth item concerning dental extraction. In addition, the graphics and instructions were 
updated in the revised SFP (Buchanan, 2010). 
 
1.1.2.2.6  Modified Child Dental Anxiety Scale (MCDAS) 
MCDAS has been developed by Wong and Humphris based on the concept of CDAS 
(Wong and Humphris, 1998). It consists of eight questions to measure dental anxiety about 
specific dental procedures. Four questions are similar to those of the CDAS in addition to 
questions likely to distress children such as how the child feels about injections, extraction 
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and general anaesthesia. A five-point Likert scale with answer options arranged in 
ascending order of the dental anxiety level is used to assess anxiety: relaxed/not worried, 
very slightly worried, fairly worried, worried a lot and very worried. The total score ranges 
from 8 to 40. The scale has a good test-retest reliability and internal consistency (0.84) 
(Howard and Freeman, 2007). It has been used in 8 to 15-year-olds and has shown a good 
internal consistency and validity. The MCDAS has an advantage over the CFSS (discussed 
below) in being shorter, thus faster to complete. It is beneficial in planning interventions 
that aim to reduce dental anxiety (Guinot et al., 2011).  
A faces version of the MCDAS  (MCDASf) has been introduced for assessing dental 
anxiety in young children by adding a faces rating scale above the original numeric form 
(Howard and Freeman, 2007). 
 
1.1.2.2.7  Children`s Fear Survey Schedule (CFSS) 
CFSS consists of 80 items on a five-point Likert-scale. The significant length of this scale 
has resulted in the development of a shorter version called the Dental Subscale of the 
Children`s Fear Survey Schedule (CFSS-DS). It involves 15 items, and each item can be 
given five different scores ranging from “not afraid at all” (1) to “very much afraid” (5). It 
has a total score range from 15 to 75, with a score of 38 or more indicating clinical dental 
fear. The scale has a good internal consistency (0.85-0.92) (Howard and Freeman, 2007). It 
is precise and provides detailed data for a dental clinic (Guinot et al., 2011). Aartman and 
co-workers argued that CFSS-DS is to be preferred to both CDAS and VPS for the 
following reasons (Aartman et al., 1997): 
 It covers more aspects of the dental situation 
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 It measures dental fear more precisely than the other scales 
 Normative data are available on this scale  
 It has slightly superior psychometric properties 
 
1.2  BEHAVIOUR MANAGEMENT TECHNIQUES IN PAEDIATRIC DENTISTRY 
1.2.1  Nonpharmacological Techniques 
These are the techniques that a paediatric dentist could utilise to create a positive attitude 
towards the dental environment and procedures on the patients’ part so that future dental 
visits become more comfortable and pleasant (Wright, 1975, Wright et al., 1987, Chadwick, 
2002). 
 
1.2.1.1 Preparatory information  
Parental anxiety is one of the known factors that have been implicated in the aetiology of 
dental anxiety of children. Therefore, strategies that have been used to decrease parental 
anxiety, such as pre-appointment letters, may help the child patient in his/her dental visit.
 
These are usually in the form of a letter welcoming the new patient and family to the 
practice. Such letters give an overall idea about what will happen at the visit, give advice on 
preparing the child, and help to reduce parental anxiety and in turn, the child’s anxiety 
(Rosengarten, 1961, Bailey et al., 1973, Wright et al., 1973a, Chadwick, 2002). Wright and 
colleagues have demonstrated the beneficial effect of a pre-appointment letter sent to 
parents of new paediatric patients. The five paragraphs letter compliments the parents for 
being concerned about their child’s dental health, states what will be done at the first 
appointment, and encourages the parents to be calm and natural when telling their child 
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about their appointment with the dentist. Children of parents, who received the letter, were 
more cooperative in the dental clinic when compared to children whose parents did not 
receive the letter. In addition, maternal anxiety was less in the pre-appointment letter group 
(Wright et al., 1973b).    
 
1.2.1.2  Non-verbal communication  
This form of communication occurs constantly during a dental visit and may emphasise or 
oppose verbal signals. Having a child-friendly environment and a happy, smiling dental 
team could be included in the context of such communication (Wright et al., 1987). 
Moreover, gentle pats and squeezes on the shoulder have been found to minimise distress 
(Weinstein et al., 1982, Chadwick, 2002).  
 
1.2.1.3  Voice control  
Young children often show better response to the tone of voice rather than the actual words 
(Wright et al., 1987). Voice control techniques involve using a controlled alteration of 
voice, volume, tone or pace to influence and direct a patient's behaviour. Such techniques 
aim to improve attention and compliance as well as to establish authority. For example, a 
sudden change from soft to firm voice would gain the attention of a child who is not 
complying. In this case, what the dentist says is not as important as the way it is said 
because the aim is to create a direct influence on behaviour rather than through 
understanding (Feigal, 2001). Voice control has been shown to decrease disruptive 
behaviours without producing long-term negative effects (Greenbaum et al., 1990). 
Nevertheless, while reported as widely used by dentists
 
it may not be acceptable to all 
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parents
 
or clinicians. The technique is useful for inattentive but communicative children 
(Murphy et al., 1984, McKnight-Hanes et al., 1993, Roberts, 1995). However, it is not 
suitable for very young children or for those with intellectual or emotional problems 
(Chadwick, 2002).  
 
1.2.1.4  Tell-show-do (TSD)  
This technique is largely used to familiarise child patients with a procedure that is unknown 
to them (McKnight-Hanes et al., 1993). This simple approach aims to introduce a new 
experience, whilst minimising fear of the unknown. The first stage (tell) is a description of 
the procedure that is about to be performed, secondly, the procedure is demonstrated to the 
child and finally it carried out (Fayle and Tahmassebi, 2003).  The “tell” phase involves an 
age appropriate explanation of the procedure. The “show” phase is used to physically 
demonstrate the procedure, for example demonstrating the practice of polishing with a slow 
handpiece on a finger. The “do” phase is initiated with a minimum delay, in this case a 
polish. It is important that the language used is appropriate to the child’s age, which is 
frequently termed in the literature as ‘childrenese’. Many dentists use a personal version of 
this ‘childrenese’ and the whole dental team must adopt the same approach. An example of 
this childrenese language is to use the word “hoover” to describe the suction (Fayle and 
Crawford, 1997). An example of ‘childrenes’ is presented in Table 1.3. Specifically 
emotive or negative words like “pain” or “blood” should be avoided. It has been shown to 
be an effective way of reducing anticipatory anxiety in new child patients (Carson and 
Freeman, 1998). This technique is contraindicated only in patients who are unable to 
communicate (Chadwick, 2002). 
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Table 1.3 Example of Childrenese Terms for Dental Equipment  
(from Fayle and Crawford, 1997) 
Actual Terms Childrenese Terms 
Low speed handpiece Buzzy bee 
High speed handpiece Whizzy brush or Mr. whistle 
Triplespray/ inhalation sedation Magic wind 
Local anaesthesia Jungle juice 
Administering local anaesthesia Spray your teeth off to sleep 
Rubber dam Rubber raincoat 
Rubber dam clamp Clip  or button 
Fissure sealant Tooth paint 
 
1.2.1.5  Enhancing control  
In this technique, the patient is given a degree of control over their dentists' behaviour 
through the use of a stop signal. Such signals have been shown to reduce pain during dental 
treatment (Wardle, 1982). The stop signal, usually raising a hand, should be practiced and 
the dentist should quickly respond to it when used (Thrash et al., 1982, Feigal, 2001, Fayle 
and Tahmassebi, 2003). Again, this technique is useful for all patients who can 
communicate (Chadwick, 2002). Allen and co-workers reported that enhancing control as a 
behaviour management technique has decreased the disruptive behaviour in children aged 
3-7 years. They also found that this strategy did not require extra time to bring the 
disruptive behaviour under control compared to other behaviour management techniques 
(Allen et al., 1992).
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1.2.1.6  Behaviour shaping and positive reinforcement  
Many dental procedures require fairly complex behaviours and actions from the patients 
which need to be explained and learned. For children, this requires small clear steps. This 
process is termed behaviour shaping. It consists of a defined series of steps towards ideal 
behaviour (Wright, 1975). In other words, it is a technique that involves developing an 
appropriate behaviour by reinforcing sequential approximations to the desired behaviour 
until it is accomplished (Fayle and Tahmassebi, 2003).  This is most easily achieved by 
selective reinforcement. Reinforcement is the strengthening of a pattern of behaviour, 
increasing the probability of that behaviour being displayed again in the future (Sawtell et 
al., 1974). Anything that the child finds pleasant or rewarding can act as a positive re-
inforcer; stickers – for example – can be used at the end of a successful appointment. 
However, the most powerful re-inforcers are social stimuli, such as, facial expression, 
positive voice modulation, or verbal praise. A child-centred, empathic response giving 
specific praise, for example, “I like the way you keep your mouth open” has been shown to 
be more effective than a general comment such as “Good boy” (Weinstein and Nathan, 
1988). As with TSD the use of age specific language is crucial (Wright et al., 1987). The 
Inability to communicate is the only contraindication to the use of this technique 
(Chadwick, 2002). 
 
1.2.1.7  Modelling  
This technique is based on the psychological principle that people normally know about 
their environment by observing the behaviour of others. Therefore, by using a model, either 
live or by video to exhibit appropriate behaviour in the dental environment might be very 
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effective in behaviour management (Ghose et al., 1969, Johnson and Machen, 1973, 
Machen and Johnson, 1974, Stokes and Kennedy, 1980). This may demonstrate appropriate 
behaviour via a third party, decrease anxiety by showing a positive outcome to a procedure 
a child requires themselves, and illustrate the rewards for performing appropriately.
 
To 
achieve the best effects, models should be the same age as the target child, should exhibit 
appropriate behaviour and be praised (Fayle and Tahmassebi, 2003). They should also be 
shown entering and leaving the surgery (Melamed et al., 1975). Where an appropriate 
model is available, this technique would be very useful (Chadwick, 2002). 
 
1.2.1.8  Distraction  
This approach aims to shift the patient’s attention from the dental setting (i.e. potentially 
unpleasant experience) to a totally different situation (Fayle and Tahmassebi, 2003). Some 
studies have advocated the use of audio tapes as effective means of distraction (Ingersoll et 
al., 1984).
 
Short-term distractors such as diverting the attention by pulling the lip as a local 
anaesthetic is given or asking the patients to raise their legs to stop them from gagging 
during radiography may also be useful. Talking during the application of the topical paste 
or administering local anaesthetic is also considered a form of distraction with words 
(Wright et al., 1987). The technique is useful for all patients who can communicate verbally 
(Chadwick, 2002).  
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1.2.1.9  Systematic desensitisation  
This technique helps individuals with specific fears to overcome them by repeated contacts. 
A hierarchy of fear-producing stimuli is constructed, and the patient is exposed to them 
gradually, starting with the stimulus posing the lowest threat. The fundamental 
psychological principle underlying systemic desensitisation is that it is not possible to 
experience two mutually incompatible psychological responses at the same time, e.g. it is 
not possible to be concurrently relaxed and anxious about a certain thing or situation (Fayle 
and Tahmassebi, 2003). In the dental treatment situation, fears are usually related to a 
specific procedure like the use of local anaesthetic; in which case, the patient is taught to 
relax first, and then exposed to each of the anxiety-provoking stimuli in the hierarchy, only 
progressing to the next when they feel able. For true phobias several relaxation sessions 
with a psychologist or dentist who has received training in relaxation or hypnosis 
techniques may be required (Wright et al., 1987).
 
Actually one reported case required nine 
separate one hour-long sessions with a therapist (Gale and Ayer, 1969).
 
The technique is 
useful for children who can clearly identify their fears and who can verbally communicate 
(Chadwick, 2002).  
 
1.2.1.10  Negative reinforcement  
Negative reinforcement is where an unpleasant or undesirable stimulus is applied to all 
behaviours being exhibited and is only removed immediately after the desired behaviour is 
displayed, thus reinforcing the preferred behaviour (Fayle and Tahmassebi, 2003). It should 
not be confused with punishment, which is the application of an unpleasant stimulus to 
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inappropriate behaviour. Well known examples in dental practice are selective exclusion of 
the parent (SEP) and hand over mouth (HOM) techniques (Chadwick, 2002). 
To use the technique of selective exclusion of the parent (SEP), parental consent is 
required. When inappropriate behaviour is exhibited the parent is asked to leave. Ideally, 
the parent should be able to hear, but be out of sight of the child. When appropriate 
behaviour is exhibited the parent is asked to return, thus reinforcing that behaviour 
(Chadwick, 2002). 
Hand-over-mouth (HOM) involves placing a hand over the child’s mouth (to allow the 
child to hear). The nose must not be covered. The dentist then talks softly to the child 
explaining that the hand will be removed as soon as crying stops. As soon as this happens 
the hand is removed and the child is praised. If protests start again the hand is replaced. 
This technique aims to gain the child’s attention and allow communication, re-inforce good 
behaviour and establish that avoidance is futile. Those who advocate the technique 
recommend it for children aged 4-9 years when communication is lost or during temper 
tantrums (AAPD, 1994, Fayle and Crawford, 1997).
 
Parental consent is important and the 
technique should never be used on children too young to understand or with those who 
suffer intellectual or emotional impairment (Levitas, 1974). 
Although still utilised in North America,
 
HOM technique remains controversial. Its use was 
supported in some studies (Wright et al., 1987, Barton et al., 1993); while other studies 
revealed that it was not acceptable to parents (Fields et al., 1984) and that dentists think it 
should never be used (Newton et al., 2004). There have been no studies on the effectiveness 
of HOM (Chadwick, 2002). Its legality (regarding restraint and individual rights) has also 
been questioned (Roberts, 1995). Nowadays, the use of HOM is not acceptable and it has 
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been eliminated from the American Academy of Paediatric Dentistry clinical guidelines on 
behaviour management in 2006 (Oueis et al., 2010) for the following reasons: 
 The available literature showed that HOM effectiveness is not evidence-based. 
 The utilisation of the technique as well as its teaching has declined dramatically 
over the years. 
 The acceptance of this technique by parents has significantly declined too. 
Hand-over-Mouth with Airway Restriction (HOMAR) is another controversial behaviour 
management technique similar to HOM but more aversive. In a study done to investigate 
behavior management techniques use among paediatric dentists practicing in the 
southeastern United States it was found that the majority of participants (90.5%) have never 
used HOMAR. The results revealed that there was significant association between age and 
use of HOMAR. The younger dentists (under 30 years) were more likely to respond that 
they have “never used” HOMAR than did older dentists, especially the over 50 years age 
group. The older dentists were the most likely to report that they “sometimes use” HOMAR 
(Carr et al., 1999). A study by Acs and colleagues has found that there is a change in the 
perspective of using HOMAR over the years in postdoctoral paediatric dental education. 
This study showed that there was a significant reduction in the use of HOMAR (only one 
program director reported its use) (Acs et al., 2001). 
 
1.2.2  Pharmacological Techniques  
These techniques involve the administration of a drug or a combination of drugs that are 
centrally-acting to help in the management of patients’ anxiety or disruptive behaviour 
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(Heasman, 2008). Pharmacological behaviour management techniques could be broadly 
divided into two categories: conscious sedation and general anaesthesia (Wilson, 2004). 
 
1.2.2.1  Conscious sedation 
Conscious Sedation is defined by the Standing Dental Advisory Committee (2003) as: 
“A technique in which the use of a drug or drugs produces a state of depression of the 
central nervous system enabling treatment to be carried out, but during which verbal 
contact with the patient is maintained throughout the period of sedation. The drugs and 
techniques used to provide conscious sedation for dental treatment should carry a margin 
of safety wide enough to render loss of consciousness unlikely.” 
The level of sedation must be within a limit that ensures that the patient remains conscious, 
maintains the protective reflexes and understands and responds to verbal commands. In any 
case where these criteria are not fulfilled and a state of ‘deep sedation’ occurs, this must be 
considered as a case of general anaesthesia (General Dental Council, 1997). The three most 
common techniques of sedation used in dentistry are: inhalation, oral and intra-venous 
sedation. These techniques are effective and adequate for most of the patients (Standing 
Dental Advisory Committee, 2003). In the literature, intra-muscular, intra-nasal and rectal 
sedation were also suggested as other methods of sedation for dental treatment (Roberts et 
al., 1996, Hosey, 2002). The required technique should be selected so that it provides the 
most appropriate and yet the least interventional method of anxiety relief for the individual 
patient. As a general rule the simplest technique to match the requirements should be 
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employed (Standing Dental Advisory Committee, 2003). The use of conscious sedation for 
dental treatment aims to reduce anxiety and improve cooperation so that treatment can be 
completed successfully without resorting to general anaesthesia (Roberts and Rosenbaum, 
1991, Standing Dental Advisory Committee, 2003). The objectives of conscious sedation 
are (Lindsay and Roberts, 1980): 
 To enable the delivery of quality dental care 
 To manage disruptive behaviour 
 To bring the patient back relatively quickly to a physiological state in which it is 
safe to go home 
 To produce a positive psychological response to dental treatment  
A child of any age who appears unwilling or incapable to cooperate in the dental chair may 
well be unsuitable for conscious sedation. Obviously there are circumstances where 
conscious sedation is inappropriate and where referral to general anaesthesia should be 
considered (Standing Dental Advisory Committee, 2003). A Study by Ashley and co-
workers revealed that there was  a slight difference between referring dentists’ views of 
sedation or general anaesthetic for the provision of dental treatment for uncooperative 
children (Ashley et al., 2010). 
Conscious sedation must only be carried out by teams that have adequate training and 
experience in case selection, behaviour management and administration of sedation for 
children and only in an appropriate setting. It should be an adjunct to rather than a 
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substitute for the non-pharmacological behaviour management techniques (General Dental 
Council, 1997, Standing Dental Advisory Committee 2003). 
 
1.2.2.1.1  Inhalation Sedation 
Techniques of inhalation sedation tend to vary in popularity. Alternative terminology of 
inhalation sedation included relative analgesia and inhalation psychosedation (Hosey, 
2002). Inhalation sedation with nitrous oxide/oxygen mixture is the first choice for child 
patients who are unable to tolerate dental treatment with local anaesthesia alone and who 
have a sufficient ability to communicate. It is usually offered to children with mild to 
moderate anxiety to facilitate a treatment that is anticipated to be complex like 
comprehensive dental treatment that requires several visits or multiple extractions 
(Crawford, 1990, Shaw et al., 1996, Hosey, 2002). Nevertheless, there are other sedative 
agents (e.g. sevoflurane) that have been used for the employment of inhalation sedation 
(Hosey, 2002, Soldani et al., 2010).  
 
1.2.2.1.1.1  Inhalation sedation agents 
Nitrous oxide/oxygen (N2O/O2) mixture 
It is well established nowadays that inhalation sedation with nitrous oxide/ oxygen 
(N2O/O2) mix is the first choice of conscious sedation employed in paediatric dentistry 
(Hosey, 2002). The basic pharmacology of nitrous oxide gas is briefly discussed below.  
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Nitrous oxide (N2O) is a colourless and almost odourless gas with a slightly sweet smell 
(Girdler and Hill, 1998, Paterson and Tahmassebi, 2003). It has a specific gravity of 1.53 
which means that it is 1.5 times heavier than air and tends to collect at floor level (Girdler 
and Hill, 1998). When N2O is inhaled into the lungs, it has a rapid uptake as it is quickly 
absorbed from the alveoli and is held in a simple solution in the serum. The alveolar 
concentration of N2O rapidly reaches the inspired concentration. As N2O is relatively 
insoluble, it passes down a gradient into other tissues and cells in the body like the central 
nervous system (CNS). Consequently, equilibration between the level of N2O in the alveoli 
and that in the blood will be rapid and in turn, induction and recovery will be extremely 
quick (Girdler and Hill, 1998). The concentration of N2O that is needed to produce sedation 
shows a discrepancy among individuals. Nitrous oxide is rapidly excreted from the lungs. 
Once N2O is no longer being inhaled, N2O within the CNS will rapidly pass down the 
gradient into the bloodstream and out of the body via the lungs. A very small amount is 
excreted in body fluids. Nitrous oxide is 34 times more soluble in blood than nitrogen and, 
hence, diffusion hypoxia may occur. This is the reason for the importance of administering 
100% oxygen for 3–5 minutes to the patient once the N2O has been turned off (Paterson 
and Tahmassebi, 2003).  
Nitrous oxide is a good but mild sedative agent. It produces both euphoria and a depressant 
effect on the CNS and therefore, memory, attention and intelligence are reduced (Girdler 
and Hill, 1998, Paterson and Tahmassebi, 2003). It has little effect on the respiratory 
system and it is non-irritant to the mucosa. It causes negligible depression in cardiac output 
whilst peripheral resistance is slightly increased, thus maintaining the blood pressure 
(Paterson and Tahmassebi, 2003).  
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N2O is a slightly potent analgesic. It was found to significantly minimise the intensity of 
pain experienced during cavity preparation in primary dentition (Hammond and Full, 
1982). A concentration of 50% inhaled N2O has been equated to that of a standard dose of 
parenteral morphine injection; thus, it would help in decreasing the pain of injections in 
those who require local anaesthesia (Girdler and Hill, 1998).  
 
Sevoflurane 
In the field of sedation research, sevoflurane is receiving a lot of attention as a possible 
sedative agent for use in dentistry. It is sweet-smelling, non-flammable and volatile gas. It 
is used for the induction and maintenance of general anaesthesia. It is a potent agent with a 
minimum alveolar concentration (MAC) value of below 2, leaving it with a narrow margin 
of safety. If sevoflurane is to be used in sedation, it is necessary to use a specialised 
vapouriser to ensure that its level is kept to a sub-anaesthetic value of 0.3% (Girdler and 
Hill, 1998).  Its use in children’s dentistry should be limited until further research emerges 
(Hosey, 2002). There were two studies comparing the use of sevoflurane in addition to 
N2O/O2 to the use of N2O/O2 alone for inhalation sedation in paediatric dentistry. The first 
was a randomised clinical trial (based in Newcastle, UK) which reported that there was a 
significant difference between standard nitrous oxide inhalation sedation and sevoflurane 
inhalation sedation. This difference was in favour of the latter technique. The study 
concluded that using sevoflurane in combination with nitrous oxide was a safe and efficient 
method of inhalation sedation when administered by an anaesthetist (Lahoud and Averley, 
2002). Nevertheless, it should be taken into account that they used a fixed concentration of 
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N2O (40%) for all the patients throughout all the appointments in both sedation techniques, 
which is not in compliance with the current guidelines concerning the need to titrate the 
concentration of the sedation agent to the individual child’s needs (Soldani et al., 2010). 
The second study was a randomised controlled, double blinded, cross-over pilot trial. It was 
carried out to compare the relative effectiveness of inhalation sedation using (A) nitrous 
oxide and oxygen with (B) nitrous oxide, oxygen and sevoflurane in the management of 
children receiving dental extractions and secondly, to determine patient and guardian 
preference between the two sedation techniques. The results showed that there was no 
statistically significant difference between the two methods of sedation. There was, 
however, a small but significant patient preference in favour of method B (Soldani et al., 
2010).  
 
Methoxyflurane  
There is evidence that methoxyflurane has been used earlier in dental sedation research. In 
a study by Edmunds and Rosen comparing nitrous oxide and methoxyflurane for inhalation 
sedation the authors felt that the patients were significantly less cooperative during 
treatment when methoxyflurane was used (Edmunds and Rosen, 1975). Nephrotoxicity has 
been linked to the use of methoxyflurane; yet this is unlikely in low concentration (Girdler 
and Hill, 1998). 
 
Other inhalation sedation agents 
Although other inhalation sedation agents such as isoflurane and halothane have been 
reported, their use should be limited until more research emerges (Girdler and Hill, 1998). 
28 
 
 
 
1.2.2.1.1.2  Advantages of inhalation sedation  
One of the advantages of inhalation sedation is its rapid onset of action compared to that of 
oral, rectal, intra-nasal or intra-muscular sedation. In addition, peak clinical effect does not 
develop in most techniques for a considerable time. Although variations do exist, peak 
clinical actions do not develop for most orally, rectally, intra-nasally and intra-muscularly 
administered drugs for a period of time, which makes titration impossible. Only inhalation 
and IV drug administration provide peak clinical actions in a time span permitting titration. 
For the IV route, time-to-peak effect varies with the drug administration ranging from 1 
minute to approximately 20 minutes. On the other hand, the inhalation route has a 3 to 5 
minute peak action. Another advantage is that the depth of sedation achieved with 
inhalation sedation may be altered from moment to moment, permitting the drug 
administrator to increase or decrease the depth of sedation easily. With no other techniques 
of sedation does the administrator have such control over the clinical actions of the drugs. 
The degree of control represents a significant safety feature of inhalation sedation (Paterson 
and Tahmassebi, 2003, Malamed, 2009). The duration of action is an important 
consideration in the selection of a pharmaco-sedative technique in an outpatient. In 
situations in which a sedation technique has a relatively fixed duration of clinical activity, 
dental treatment must be tailored to this, whereas in those techniques with a flexible 
duration of action, the planned procedure may be of any length. With inhalation sedation 
the duration of action is variable just at the preference of administrator (Malamed, 2009). 
Moreover, recovery time from inhalation sedation is rapid and is the most complete of any 
pharmaco-sedation technique. As discussed, titration is the ability to administer small, 
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incremental doses of a drug until a desired clinical action is obtained. It is thought that the 
ability to titrate a drug represents the greatest safety feature a technique can possess 
because it permits the drug administrator virtually absolute control over the actions of the 
drug (Stewart, 1985). Significant drug overdose will not develop in techniques in which 
titration is possible as long as the administrator does indeed titrate the drug. In an outpatient 
setting, it is advantageous for the patient to be discharged from the office following a 
procedure with no prohibitions on activities (Paterson and Tahmassebi, 2003, Malamed, 
2009).  
Unfortunately, because all of the drugs administered for the reduction of fear and anxiety 
are central nervous system (CNS) depressants, the patient may not be permitted to leave the 
office unescorted to operate a motor vehicle or to perform tasks requiring mental alertness 
for a number of hours following the administration of these drugs. To do so is to increase 
the potential risk to both the patient (physical risk) and the dentist (legal risk). Recovery 
must be complete, with absolutely no doubt in the mind of the dentist that the patient is able 
to function normally; if not, the patient should not be permitted to leave the office 
unescorted. With inhalation sedation, recovery is almost always complete; patient usually 
may be discharged from office alone, with no cautions about activities. One of the most 
important advantages of inhalation sedation is that no injections are required for the 
administration (although local anaesthesia is still necessary) (Paterson and Tahmassebi, 
2003, Malamed, 2009). 
As N2O is the preferred drug for the employment of inhalation sedation, the advantages of 
N2O use in particular for IHS are further discussed below (Hosey, 2002, Foley, 2005, 
Woolley et al., 2009) . N2O/O2 is safe; very few side-effects are associated with its use. The 
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drugs used in this technique have no adverse effects on the liver, kidneys, brain, or 
cardiovascular and respiratory systems (Hosey, 2002). Because N2O is not metabolised by 
the body, the gas is rapidly and virtually completely eliminated from the body within 3 to 5 
minutes. In all other techniques, the recovery from sedation is considerably slower (Faddy 
and Garlick, 2005).  Lastly, inhalation sedation with N2O/O2 can be used instead of local 
anaesthesia in certain procedures. N2O does possess analgesic properties when given in the 
usual sedative concentrations (Hammond and Full, 1982, Malamed, 2009). Certain 
procedures, such as those involving soft tissues (e.g. scaling), may be performed in many 
instances without using local anaesthesia (Paterson and Tahmassebi, 2003, Malamed, 
2009). 
It is worth mentioning here that the analgesia produced by a 20% concentration of N2O is 
equivalent to that of 10 to 15 mg of morphine (Girdler and Hill, 1998). However, the 
degree of analgesia is quite variable from patient to patient and therefore cannot be relied 
on to provide all of the pain control required for a procedure (Paterson and Tahmassebi, 
2003, Malamed, 2009). 
 
1.2.2.1.1.3 Disadvantages of inhalation sedation  
In spite of the fact that inhalation sedation for dental treatment has many advantages, there 
are a number of issues that make inhalation sedation disadvantageous in certain situations. 
The following are disadvantages associated inhalation sedation (Malamed, 2009): 
 It is quite expensive to install and use the inhalation sedation armamentarium as 
the initial cost of the equipment is high as well as the continuing cost of 
consuming the gases.  
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 The equipment required for inhalation sedation occupies considerable space 
within the dental surgery room.  
 A degree of cooperation is required from the patient. For inhalation sedation to 
be effective, the patient must be able to inhale the gases through the nose. 
Should the patient be unable (due to certain medical conditions for example) or 
unwilling to do so, clinical failure will result. 
 All members of the sedation team must receive training in its safe and effective 
use (Hosey, 2002).  
 The nasal hood that is required to administer the sedative gas could be 
problematic (Paterson and Tahmassebi, 2003): 
o Its position close to the operation site might interfere with some 
procedures like in injections in the upper anterior region. 
o It can be displaced during patient movement which will break the nasal 
seal rendering the sedation less effective and exposing the staff to the 
sedative gas. 
o It might be rejected by some children especially those with a previous 
history of GA. 
 There is a possibility that unscavenged traces of nitrous oxide can be deleterious 
in the long term (Paterson and Tahmassebi, 2003).  
o Chronic exposure to N2O was found to cause haematological 
abnormalities and reproductive problems for members of the dental team 
(Spence, 1987, Rowland et al., 1995, Hoerauf et al., 1999). 
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 N2O is not a potent agent. When it is used in combination with at least 20% O2, 
there will be a small percentage of patients in whom the technique will fail to 
produce the desired clinical actions. In no circumstance should N2O ever be 
administered with less than 20% O2. Failures will occur primarily because of the 
lack of potency of the agent or due to the administration and/or titration 
technique. This effect can be influenced by the semi-hypnotic approach and 
psychological preparation of the patient (Hosey, 2002). Therefore, the great 
dependence on psychological reassurance to achieve the best effect could be 
considered a disadvantage  (Paterson and Tahmassebi, 2003).  
 
1.2.2.1.1.4 Indications and contra-indication of inhalation sedation  
The management of dental fear and anxiety is the primary indication for the use inhalation 
sedation (Girdler and Hill, 1998, Hosey, 2002, Paterson and Tahmassebi, 2003, Malamed, 
2009). The indications for the use of inhalation sedation are outlined in Table 1.4. 
 The contra-indications to relative analgesia sedation are only relative rather than absolute 
(Roberts, 1990a, Roberts, 1990b, Girdler and Hill, 1998, Paterson and Tahmassebi, 2003). 
It is essential to balance the risk of giving the patient sedation against the risk of 
administering general anaesthesia, which is in many cases the only option for severely 
anxious patients (Paterson and Tahmassebi, 2003). The contra-indications to inhalation 
sedation are summarised in Table 1.4 below. 
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Table 1.4 Indications and Contra-Indications of Inhalation Sedation  
 [Adapted from Hosey (2002), Paterson & Tahmassebi (2003) and Malamed (2009)] 
Indications Contra-indications 
 Fear or anxiety 
 Needle phobia 
 Where more profound local anaesthesia 
cannot be obtained, e.g. acute pulpitis; 
hypoplastic teeth 
 Gag reflex 
 Prolonged or unpleasant treatment, e.g. 
surgical extractions 
 Persistent fainting 
 An alternative to GA for some special 
needs/medically compromised patients 
like sickle cell disease or trait, some 
cardiac conditions and cerebral palsy 
 Cardiovascular disorders (because  N2O 
reduces anxiety, elevates the pain 
threshold and provides increased levels 
of oxygen) 
 Liver/kidney disease (as N2O does not 
undergo biotransformation in the body) 
 Severe asthma (as a high oxygen 
tension is maintained) 
 Inability to communicate 
 Fear of the mask 
 Mouth breathing 
 Unwilling/unable to nose breathe 
 Cold/rhinitis 
 Chronic obstructive airways disease, e.g. 
emphysema, chronic bronchitis (because 
the lowered blood oxygen level is the 
stimulus for breathing) 
 Severe muscular depression activity, e.g. 
multiple sclerosis 
 Severe psychiatric disorders 
 Behavioural/personality problems 
 Learning difficulties 
 Psychological (i.e. patient disliking the 
felling of loss of control) 
 First trimester of pregnancy  
 Bleomycin chemotherapy  
 Otitis media (because N2O causes 
pressure volume effects on the ear) 
Key: 
GA: General Anaesthesia 
N2O: Nitrous Oxide 
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1.2.2.1.2  Intra-venous sedation 
Intra-venous sedation for children is only appropriate in a limited number of cases and 
should only be provided by those who are trained and experienced in sedation for children 
as well as the administration of intra-venous drugs (Hosey, 2002, Scottish Intercollegiate 
Guideline Network, 2004, Girdler et al., 2009). Its use may be indicated in older children 
for whom inhalational sedation has been unsuccessful (Standing Dental Advisory 
Committee, 2003).  
 
1.2.2.1.2.1  Pharmacology of intra-venous sedation 
Induction of sedation 
(Girdler et al., 2009, Giovannitti Jr, 2013) 
Upon IV injection, the plasma level of a sedative drug will rise rapidly. The agent will pass 
through the venous system to the right side of the heart. Once in the arterial system it will 
reach the brain, but it will only start to have its effect once diffusion across the lipid 
membranes has occurred. The final plasma concentration of the sedative agent depends on 
a) total dose of drug, b) rate of injection, c) cardiac output, and d) circulating blood volume. 
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Recovery from sedation 
(Girdler et al., 2009, Giovannitti Jr, 2013) 
Recovery from sedation occurs in two manners: 
1. Redistribution of the sedative agent from the CNS into the body fat 
2. Uptake and metabolism of the sedative agent in the liver and elimination via the 
kidneys 
The initial peak plasma concentration forces the sedative agent into tissues that are well 
perfused such as the brain. As time passes, more of the sedative agent is taken up into the 
adipose tissues. The high mass of body fat and the lipid solubility of sedative agents do 
promote redistribution to the fat stores. Ultimately the plasma concentration of drugs 
decreases and the blood-brain concentration gradient is reversed. This forces the sedative 
agent out of the brain and back into the blood stream. 
The uptake, metabolism and elimination result in a final reduction in plasma concentration 
leading to complete recovery for the patient. 
In general, redistribution is responsible for the initial recovery from sedation, followed by 
elimination of the remaining drug. In comparing different drugs, it is the elimination half-
life that can be used to compare the pharmacokinetic effects of different sedative agents. 
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1.2.2.1.2.2  Intra-venous sedation agents 
Benzodiazepines: Diazepam 
Diazepam is the first benzodiazepine agent to be utilised for IV sedation. Nevertheless, due 
to its relative insolubility in water, it has to be dissolved in an organic solvent. This solvent 
formulation caused a high incidence of vein damage; that is why it is no longer used. 
Diazelmus is a non-irritant preparation that overcomes the problem of venous damage. 
Diazepam is metabolised in the liver and eliminated via the kidneys. It has a long 
elimination half-life of about 43 hours, while the distribution half-life is 40 minutes. The 
active metabolite (n-desmethyldiazepam) can cause rebound sedation for up to 72 hours 
following initial administration. For that reason, in addition to the long recovery period, 
diazepam has been considered unsuitable as a sedative agent for short dental procedures 
and its use has largely been superseded by midazolam (Girdler et al., 2009). According to 
the UK national clinical guidelines in paediatric dentistry, there is no role for intra-venous 
diazepam sedation in paediatric dentistry (Hosey, 2002). 
 
Benzodiazepines: Midazolam 
Midazolam was first employed in clinical practice in the early 1980’s (Meechan et al., 
1998, Girdler et al., 2009). Nowadays, midazolam is the sedative agent of choice for IV 
sedation in dentistry (Girdler et al., 2009). IV midazolam is recommended for adolescents 
who are psychologically and emotionally suitable (Hosey, 2002). Midazolam is an 
imadazobenzodiazeine that is water soluble, has a pH value of less than 4 and is non-irritant 
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to veins. Once injected into the blood stream at physiological pH, it becomes lipid soluble 
and is readily able to penetrate the blood-brain barrier. It is rapid acting and has an 
elimination half-life of 1.9 hours. It is mainly metabolised in the liver with some 
metabolism occurring in the bowel. The active metabolite is alpha-hydroxymidazolam and 
it has a short half-life of 1.25 hours so there is no true rebound sedation. The administered 
dose should be titrated according to the patients’ response, most require a dose in the range 
of 0.07-0.1 mg/kg (Kupietzky and Houpt, 1993, Girdler et al., 2009). The UK national 
clinical guidelines in paediatric dentistry suggest that IV midazolam should be administered 
only by an experienced dental sedationist with a trained dental nurse in an appropriate 
facility; for patients who are under 14 years of age, it should be carried out in a hospital 
setting (Hosey, 2002). In a randomised clinical pilot trial conducted to test the effect of IV 
midazolam as a conscious sedation technique for anxious children requiring dental 
treatment (Averley et al., 2004), the participant children were distributed to 3 groups: a) 
group 1 received IV midazolam with ‘medical air’, b) group 2 received IV midazolam in 
addition to 40% N2O/O2, and c) group 3 received IV midazolam together with 40% N2O/O2 
and 0.3% sevoflurane. The dentist was blinded to the group number. Fifty percent, 73% and 
83% completed treatment successfully in groups 1, 2 and 3 respectively. This pilot study 
revealed that IV midazolam especially in combination with N2O/O2 or N2O/O2 and 
sevoflurane was promising, safe and an effective technique, sufficient to justify proceeding 
with a definitive RCT with appropriate methods. Another randomised controlled, cross-
over clinical trial (Wilson et al., 2003) was performed to compare IV midazolam sedation 
with nitrous oxide sedation in children undergoing dental extractions. There were 40 
38 
 
 
patients with a mean age of 13.2 years requiring two appointments for equivalent but 
contralateral extractions for orthodontic purposes. They received conscious sedation with 
IV midazolam titrated from 0.5mg/min to a maximum of 5 mg in one visit and IHS with 
N2O/O2 titrated to 30%/70% in the other visit. Median time to maximum sedation level was 
8 minutes for midazolam and 6 minutes for N2O/O2. Vital signs for both techniques were 
similar and within acceptable clinical limits. The difference in mean recovery time (52 min 
for midazolam and 23 min for N2O/O2) was statistically significant. Of the patients 
included in the study, 51% preferred IV midazolam, 38% preferred N2O/O2 and 11% had 
no preference. The study concluded that IV midazolam sedation appeared to be as effective 
as IHS with N2O/O2 for 12-16 years old healthy paediatric patients. 
 
Benzodiazepine antagonist (Flumazenil) 
The discovery of flumazenil in 1978 was a major advance in the practice of intra-venous 
sedation. It was the first drug to effectively and completely reverse the effect of almost all 
of the benzodiazepines. It is a true benzodiazepine with almost no intrinsic therapeutic 
action. It has a greater affinity for the benzodiazepines receptors than all the other active 
drugs which rendered it an effective antagonist. It reverses temporarily the sedative, 
cardiovascular and respiratory effects of diazepam and midazolam. It has an elimination 
half-life of about 53 minutes. It is administered by giving 200mcg then waiting for a 
minute. A further 100mcg is then administered every minute until the patient is completely 
recovered (Girdler et al., 2009). Flumazenil is currently only for use in emergency 
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situations; it should not be used as a routine part of the conscious sedation procedure or as a 
way of accelerating recovery. If it were to be used for routine reversal, there is a theoretical 
risk of reoccurrence of benzodiazepine sedation once the flumazenil has worn off because it 
has a shorter elimination half-life than active benzodiazepines (Hosey, 2002, Girdler et al., 
2009). Flumazenil may also induce convulsions (Royal Pharmaceutical Society of Great 
Britain, 2012).  
 
Propofol 
Propofol is a potent IV hypnotic agent that is widely used for the induction and 
maintenance of anaesthesia and for sedation in the ICU. It has an oil form at room 
temperature and is insoluble in aqueous solution. It appears to act by enhancing the GABA 
neurotransmitter system. Propofol has a rapid recovery because its elimination half-life is 
30-40 minutes. Its distribution half-life is 2-4 minutes (therefore rapid distribution into 
peripheral tissues). Its effects wear off substantially within 30 minutes of administration. 
For the maintenance of general anaesthesia, propofol is administered as a continuous 
infusion. Upon completion of the procedure, the infusion is stopped and the patient regains 
consciousness within a few minutes. It can be administered in sub-anaesthetic doses in one 
of the following techniques (Girdler et al., 2009): 
 Target controlled infusion (TCI – consists of an infusion pump containing software 
simulating the best pharmacokinetic model for propofol) 
 Patient-controlled target infusion 
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 Intermittent bolus administration 
The use of propofol for dental sedation is still in the experimental stages and requires the 
help of a qualified anaesthetist in a hospital setting (Hosey, 2002, Girdler et al., 2009). The 
studies performed to assess the suitability of propofol as an IV sedative for dental treatment 
show promising results (Rodrigo and Jonsson, 1989, Oei-Lim et al., 1991, Stephens et al., 
1993). In a study by Hosey and co-workers (2004) that was conducted to assess the use of 
propofol for anxious children in a specialist paediatric dentistry unit, 32 out of 34 patients 
had successfully completed treatment at their first visit. The mean propofol dose injected 
was 2.5mg/kg. All procedures were performed with anaesthetist assistance. Sedation and 
recovery were uneventful for all the patients. The study concluded that sub-anaesthetic 
doses of propofol used for IV conscious sedation infusion facilitated dental treatment for 
anxious children (Hosey et al., 2004).  Another study was conducted to compare the effects 
of IHS with N2O/O2 to the influence of IV propofol on dental anxiety of children 
undergoing dental treatment. The two techniques showed comparable efficacy in reducing 
the anxiety level of the referred anxious children. It was found that participants who 
underwent IV propofol sedation were older and that IV sedation with propofol permitted 
more treatment to be carried out at each visit. It was suggested that further propofol 
conscious sedation studies were required (Alexopoulos et al., 2007). However, there were 
some limitations: the study was not randomised, there were many operators who were not 
calibrated, some patients were first enrolled in the study on their 2
nd
 sedation visit and that 
treatment offered was various.  
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1.2.2.1.2.3  Advantages and disadvantages of intra-venous sedation 
The advantages and disadvantages of the use of intra-venous sedation technique for dental 
procedures are presented in Table 1.5 Below (Meechan et al., 1998, Girdler et al., 2009). 
Table 1.5 Advantages and Disadvantages of Intra-Venous (IV) Sedation  
Advantages Disadvantages 
 Fast onset of sedation 
 Ability to titrate the sedative agent 
according to the patient’s response 
 Reasonably wide margin of safety 
between end point of sedation and loss 
of consciousness or anaesthesia 
 Relative comfort of administration 
 IV access is preserved 
 A satisfactory level of sedation is 
achieved pharmacologically rather than 
psychologically 
 Recovery happens within a reasonable 
period 
 The need to establish a venous access 
 For a short period after injection the 
laryngeal reflex might be weakened 
 Excessively rapid IV injection can cause 
significant respiratory depression 
 Adverse reactions are severe 
 Once administered, the drug cannot be 
recovered  
[Thus, the operator has to wait for the 
natural metabolism and elimination to take 
place.  The management of an overdose 
includes basic life support or the use of an 
antagonist. The antagonist will not speed up 
the elimination of the active drug but will 
block its effects] 
 Does not produce useful clinical 
analgesia (although it may alter patients 
perception about pain) 
 May cause disinhibition rather than 
sedation occasionally; so instead of 
becoming more relaxed the patient 
becomes more anxious and difficult to 
manage   
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1.2.2.1.2.4  Indications of intra-venous sedation 
Intra-venous sedation is suitable for most adult dental patients. According to the BSPD 
guidelines, IV sedation could be used as a means to manage anxious adolescents who are 
psychologically and emotionally suitable. Furthermore, IV sedation for children under the 
age of 14 years should be carried out in a hospital environment. IV sedation is helpful to 
counteract moderate to severe dental anxiety. It is a good option for claustrophobics and 
patients suffering from phobias related to anaesthetic equipment. It is indicated for 
traumatic surgical procedures and for patients with mild medical conditions which might be 
aggravated by the stress of dental treatment – e.g. mild hypertension or asthma- or those 
with mild intellectual or physical disability (Meechan et al., 1998, Girdler et al., 2009).  
 
1.2.2.1.2.5  Contra-indications of intra-venous sedation 
 IV sedation is contraindicated in the following situations (Meechan et al., 1998, Girdler et 
al., 2009): 
 History of allergy to the sedative agent (e.g. benzodiazepines) 
 Impaired renal or hepatic function 
 Pregnancy or breast feeding 
 Severe psychiatric disease 
 Drug dependency 
 Needle phobia 
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 Children: IV sedation should be approached with caution as it can have 
unpredictable effects. Children can lose their controlling inhibitions and become 
uncooperative. Even slight over-sedation could result in respiratory depression and 
airway obstruction.  
 
1.2.2.1.3  Oral Sedation 
This technique is not in general use for dentistry at present; if it is to be used, then it should 
be provided by a health care provider who is experienced in its use (Standing Dental 
Advisory Committee, 2003). The oral sedative agent should only be prescribed and given 
by the operating dentist within the facility where the dental treatment is to be performed. 
Moreover, children who had the sedative drug should be placed in a quiet room together 
with their guardian and a competent member of staff. The sedated children should be 
monitored clinically and electronically (Hosey, 2002).  
 
1.2.2.1.3.1  Oral sedation agents 
Midazolam: 
The oral formulation of midazolam was previously associated with a bad taste but now 
available in hospitals in a blackcurrant flavoured solution. It reaches the systemic 
circulation via the portal circulation. This decreases the drug’s bioavailability which 
necessitates a higher dose compared to intra-venous administration. Only 15-30% of the 
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administered oral dose reaches the systemic circulation. The onset of oral midazolam is 
variable (ranges from 15-30 minutes) and is largely dependent on the patient’s rate of 
absorption from the GIT, which can be affected by the rate of gastric clearance, amount of 
food in the stomach and time of the day. The peak plasma level is reached in 30-60 
minutes. It is recommended that a dose of 0.5-0.75 mg/kg administered 30 minutes before 
treatment. The patient then should be monitored after administration. Its duration of action 
is 30 minutes while the half-life is approximately 1.2 hours (Meechan et al., 1998, 
Hallonsten et al., 2003). The provision of oral midazolam for dental treatment of anxious 
children was found to be as effective as IHS using N2O/O2 in many papers (Wilson et al., 
2002a, Wilson et al., 2002b, Wilson et al., 2006). In a study performed to investigate the 
use of oral midazolam conscious sedation as an alternative to general anaesthesia, the 
behaviour of 74% of the participants was excellent or very good. Vital signs were 
monitored and were within clinical limits for all patients. The study concluded that oral 
midazolam was a safe and effective means of conscious sedation although some children 
were agitated and distressed either during or after treatment; for which, parents need to be 
warned (Lourenço-Matharu and Roberts, 2010). Another study has retrospectively assessed 
the effectiveness of oral midazolam in two centres, Leeds (UK) and Westmead (Australia). 
The results showed that oral midazolam doses used in Leeds were 0.5 – 0.7mg/kg while 
they were 0.2-0.3mg/kg in Westmead. Success rates were 65% and 91% in Leeds and 
Westmead respectively; the difference in success rate was statistically significant. The 
study concluded that oral midazolam was found to be a useful drug for the management of 
young children with disruptive behaviour. It suggests though that the use of oral midazolam 
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in children is limited to simple dental procedures over a maximum of two visits (Day et al., 
2006). 
 
Choral hydrate: 
Chloral hydrate was the first of the hypnotic group of drugs. In the past, it had been utilised 
for the management of dentally anxious patients. It is formed by adding one molecule of 
water to the carbonyl group of chloral and is largely used as a hypnotic agent for dental 
procedures. It has been considered the drug of choice for conscious sedation for many 
paediatric dentists because of its safety, efficacy and relatively easy oral administration 
(Avalos-Arenas et al., 1998). However, repeated administration of chloral hydrate carries a 
theoretical risk of carcinogenesis. Moreover, the use of chloral hydrate should be within a 
hospital setting (Hosey, 2002). 
 
1.2.2.1.3.2  Advantages, disadvantages, indications and contra-indications of oral sedation 
The advantages, disadvantages, indications and contra-indications of the use of oral 
sedation techniques are summarised in Table 1.6 (Meechan et al., 1998). 
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Table 1.6 Summary of Advantages, Disadvantages, Indications and Contra-
Indications of Oral Sedation 
Advantages Disadvantages 
 Low cost 
 Non-invasive 
 Ease of administration 
 Decreased incidence and severity of 
adverse reactions 
 Specialised training not vital (although 
strongly advised) 
 Compliance is crucial 
 Variable onset 
 Variable absorption 
 Inability to titrate 
 Inability to alter sedation level 
 Short duration of action 
Indications Contra-indications 
 Failure of alternatives 
 Adjunct to behaviour techniques 
 Pre-cooperative/special needs 
 Short procedures 
 Mild-moderate anxiety 
 Premedication 
 Morbid obesity 
 Sleep apnoea 
 Airway obstruction 
 Concomitant viral/tonsillar infection 
 Allergy/hypersensitivity to the sedative 
agent 
 Current medication with 
benzodiazepines, other central nervous 
system depressants or muscle relaxants 
 
1.2.2.1.4  Intra-nasal sedation 
Midazolam has been used as an intra-nasal sedative agent that is administered with a 1 or 2 
cc syringes and a mucosal atomisation device usually into alternate nares. Dose is limited 
by the volume of the solution. The recommended dose is 0.2-0.3mg/kg and additional doses 
can be repeated after 10 minutes if required. The peak plasma level is reached after 15 
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minutes. The use of intra-nasal midazolam was reported in the literature to induce allergic 
reaction which emphasise the need of close post-administration monitoring (McIlwain et 
al., 2004). 
A study by Gilchrist and colleagues assessed the use of intra-nasal midazolam in the 
treatment of paediatric dental patients. There were 20 patients aged 2-9 years who required 
simple surgical procedures. The midazolam was administered intra-nasally using a mucosal 
atomisation device (0.25mg/kg). Compliance of the full dose was achieved in 14/20 cases, 
13 of whom completed treatment. Three patients did not allow any midazolam to be 
administered. Eleven patients did not suffer any side-effects – like coughing or sneezing – 
on delivery while one patient vomited at home post-operatively. The study concluded that 
0.25mg/kg intra-nasal midazolam provided adequate anxiolysis for the majority of children 
to complete their treatment whilst maintaining stable oxygen saturation and verbal contact 
(Gilchrist et al., 2007). Another study by Fuks and co-workers was carried out to assess the 
use of two different doses of intra-nasal midazolam for sedation of young paediatric dental 
patients. There were 30 children needing at least 2 restorative appointments. They were 
randomly assigned to receive either 0.2 or 0.3mg/kg of midazolam intra-nasally in the 1
st
 
visit and the alternative regimen in the 2
nd
. Administration of 50% N2O/O2 was then 
initiated using rapid induction technique. A papoose board was also used. The results 
showed that there is no difference in behaviour, no adverse effects observed and all 
treatment was successfully completed. The study concluded that 0.2mg/kg of midazolam 
(as no difference was observed with 0.3mg/kg) was an adequate sedation modality and 
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could be recommended for dental treatment in preschool children (Fuks et al., 1994). 
However, the results of this study could not be generalised as the effect of the midazolam 
was confounded by the co-administration of N2O/O2 as well as the use of physical restraint. 
The advantages, disadvantages, indications and contra-indications of intra-nasal midazolam 
are summarised in Table 1.7 (Meechan et al., 1998). 
 
Table 1.7 Advantages, Disadvantages, Indications and Contra-Indications of Intra-
Nasal Midazolam 
Advantages Disadvantages 
 Rapid absorption 
 Rapid onset (produces sedative effect 
within 5 minutes) 
 Amnesia can be induced 
 Less cooperation is needed compared to 
oral or intra-venous routes 
 Short duration 
 Could cause a nasal burning sensation 
 Could cause respiratory depression 
occasionally 
 No analgesic effect 
Indications Contra-indications (Hosey, 2002) 
 Mild to moderate anxiety 
 Pre-cooperative 
 Copious nasal secretions or upper 
respiratory tract infection 
 Treatment to be carried out in a non-
hospital setting 
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1.2.2.2  General anaesthesia  
Some patients lack the ability to cooperate during dental treatment like those suffering from 
severe mental and/or physical impairment; hence, for such patients, treatment under general 
anaesthesia may be the only solution. Moreover, some surgical procedures are so extended 
in time and tiring that no other methods of pain and anxiety control can be considered 
(Koch and Poulsen, 2009, Welbury et al., 2012). The clinician should ensure that the 
benefits of treatment outweigh the risks when making a decision to treat a child under 
general anaesthesia. Economic factors and access to anaesthetic facilities should also be 
considered (Cameron and Widmer, 2008).  
When performed in a hospital setting, the prevalence of serious complications associated 
with dental treatment under general anaesthesia is very low. Almost certainly, general 
anaesthesia is safer than giving deep sedation to a patient in a regular dental setting. The 
indication for dental treatment under general anaesthesia, however, must be restricted 
because anaesthesia itself can exert physical and mental stress compared with the other 
treatment options (Blain and Hill, 1998, Cameron and Widmer, 2008, Welbury et al., 
2012). It should be the last resort when all efforts to treat a child in the conventional 
manner have failed (Cameron and Widmer, 2008, Koch and Poulsen, 2009). Proper consent 
should be obtained prior to the procedure as well as a thorough pre-anaesthetic assessment 
(Cameron and Widmer, 2008). The shared airway may pose a challenge to the anaesthetist 
as the operating dentist often encroaches upon the airway especially when performing 
lower arch extractions (Cameron and Widmer, 2008, Welbury et al., 2012). 
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1.3  ASSESSING THE NEED FOR DENTAL SEDAION 
It is well-known now that dental fear and anxiety could represent a barrier for seeking 
dental care. It was reported that 23 million people with dental fear would be more willing to 
visit a dentist if a form of sedation was offered (Girdler and Hill, 1998). Many studies have 
been conducted to assess the need for sedation utilising either a paper questionnaire posted 
to dental health care providers as well as the general population or via telephone contact. 
The results of these studies revealed that clinicians felt that sedation for dental treatment 
should be available to all children. In addition, respondents from the general population 
showed preference to receive sedation as a way of anxiety relief and they were more 
willing to go to the dentist more often when such services were available (Dionne et al., 
1998, Chanpong et al., 2005, Boynes et al., 2006, Chadwick et al., 2006, Woolley et al., 
2009, Abdulwahab et al., 2010).  
 
1.3.1  The Indicator of Sedation Need (IOSN) 
As discussed above, it can be argued that there are some dentally anxious patients who are 
not being offered conscious sedation to facilitate their treatment and at the same time 
sedation services may be demand rather than needs-led. For that reason Coulthard and co-
workers developed the Indicator of Sedation Need (IOSN). The IOSN is a tool – as its 
name indicates – to be used to assess the need for sedation. The IOSN can be used as a) a 
referral tool to help clinicians to make a decision about referring adult patients to have 
sedation for their dental treatment, and b) as a health needs assessment tool for 
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commissioners. It basically investigates the need for sedation by ranking a combination of 
information on patient anxiety, medical history and the complexity of the clinical treatment. 
This tool was introduced recently (September 2011) to be utilised for adult patients and not 
for children. This is because it is composed of three components; one of which – namely 
the anxiety component – is completed by the patient. This component is simply an anxiety 
scale and the scale used in the IOSN is an adult one: the Modified Dental Anxiety Scale 
(MDAS). The second component is medical status which is largely based on the patient’s 
ASA class (American Society of Anesthesiologists, 2006). The last component is the 
treatment complexity and again, the indicative list of treatment provided is based on 
treatment offered to adults. The latter two components are completed by the clinician. Each 
of these components is given a score and the sum of all of them will be the IOSN score, 
based on which a need for sedation can then be assessed. Table 1.8 describes the IOSN 
scoring tool in brief (Coulthard et al., 2011). 
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Table 1.8 IOSN Scoring Tool 
IOSN Domain Score Source 
Anxiety 1-3 Based on  MDAS score: 
MDAS between 5-11 is minimal anxiety, scores 1 
MDAS between 12-18 is moderate anxiety, scores 2 
MDAS between 19-25 is high anxiety, scores 3 
Medical history 1-4 A range of medical and behavioural indicators is 
provided; as a general rule, ASA class is utilised: 
ASA I, scores 1 
ASA II and/or strong gag reflex, scores 2 or 3 (depends 
on clinical judgment) 
ASA III, scores 4 
Treatment 
Complexity 
1-4 An indicative list of treatments is provided. If the user of 
this tool is in doubt about the complexity of any given 
treatment they are asked to score high 
IOSN metric IOSN description  Sedation need? 
3-4 Minimal need for sedation  No 
5-6 Moderate need for sedation  No  
7-9 High need for sedation Yes  
10-11 Very high need for sedation Yes  
Key: 
IOSN: Indicator of Sedation Need 
MDAS: Modified Dental Anxiety Scale 
ASA classification: American Society of Anaesthesiologists classification of physical health 
ASA I: Healthy  
ASA II: Mild Systemic Disease 
ASA III: Severe Systemic Disease (that does not pose a constant threat to life) 
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1.4  AIM OF THE STUDY 
The aim of the present study was to assess the treatment outcomes of using inhalation 
sedation for comprehensive dental care within the hospital dental service by utilising a 
modified version of the Indicator of Sedation Need (IOSN) assessment tool. 
The objectives of the present study were: 
 To retrospectively assess the outcomes of treatment under nitrous oxide/oxygen 
inhalation sedation at the Leeds Dental Institute (LDI) sedation unit.  
 To assess the outcomes of treatment under nitrous oxide/oxygen inhalation sedation 
of patients referred to the sedation unit in the LDI utilising a modified version of the 
Index of Sedation Needs (IOSN) as a health needs assessment tool on a prospective 
basis. [Note: the modified version here is abbreviated as p-IOSN] 
 To compare the results of the retrospective part of the study to the prospective part 
and identify any significant differences in the treatment completion rates. 
 
The null hypothesis for this study: 
 There is no significant difference between the completion rate of dental treatment 
under inhalation sedation with or without the use of p-IOSN of any score. 
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2.0 MATERIALS AND METHODS 
The present study was carried out in two phases:  retrospective phase and prospective 
phase. The methodology of gaining ethical approval, obtaining the data for both phases and 
statistical analysis is described in this chapter. 
 
2.1  ETHICAL APPROVAL 
Ethical approval was first sought from the Dental Research Ethics Committee (DREC) at 
the Leeds Dental Institute (LDI) (Appendix 1). Subsequently, it was sought from the 
National Research Ethics Service (NRES) committee of North West – Preston (REC 
reference number: 12/NW/0770, Appendices 2 and 3). Following this the study received 
approval  from the Leeds Research and Development Directorate (R&D) in order for it to 
be performed at the Leeds Teaching Hospital Trust (LTHT R&D number:  DT12/10541, 
Appendix 4). 
The Chief Investigator (CI: MM) made certain that the present study was carried out in full 
conformance with the laws and regulations of the country in which the research was 
conducted and the World Medical Association Declaration of Helsinki (World Medical 
Association, 2008). 
 
2.2  RETROSPECTIVE PHASE  
The clinical records of all the child patients who received dental treatment in the sedation 
unit at the LDI during the period of 2006-2011 were requested from the administrative 
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office.  The CI reviewed all the notes and transferred the following information to a data-
collection sheet (Appendix 5): 
a. Age 
b. Gender  
c. Treatment outcome  
 
2.2.1  Recording the Outcome of Treatment  
There were five possible treatment outcomes: 
1. Treatment completed as planned 
2. Modified treatment completed 
3. Treatment abandoned and child referred on to be treated under general anaesthesia  
4. Treatment abandoned in sedation unit and child referred to be treated under local 
anaesthesia 
5. Child failed to return to complete treatment 
The treatment outcome was recorded as “completed as planned” if the record showed that 
the treatment which the child patient had received was in accordance with the proposed 
treatment plan that was documented in the patient’s file. In cases where the patient received 
a modified treatment than that originally planned, then the outcome was recorded as 
“modified treatment received”. For example, if the patient had the restorations carried out 
under IHS then referred to have the extractions under GA, while the initial treatment plan 
was to perform the whole treatment under IHS, then that would be considered a modified 
treatment. There were patients who had been assessed in the sedation unit to have 
comprehensive treatment performed under IHS, but then they did not cope well with the 
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treatment, hence they were referred to have their treatment under GA. In this case the 
outcome was recorded as “treatment abandoned and child referred on to be treated under 
general anaesthesia”. On the other hand, there were patients for whom the treatment did not 
require IHS and were referred to complete their treatment under LA; in which case, the 
outcome was recorded as “treatment abandoned in sedation unit and child referred to be 
treated under local anaesthesia”. The outcome was recorded as “child failed to return to 
complete treatment” if the patient’s record showed that there was a plan to carry out their 
treatment under IHS but they never showed up to have it performed. 
 
Inclusion Criteria 
• All the patients who had undergone dental treatment under inhalation sedation at the 
LDI during the period of 2006-2011. 
• Less than 17 years of age. 
 
Exclusion Criteria 
• Patients for whom a decision was made to treat them utilising means other than IHS 
on their initial assessment visit at the sedation unit. 
 
2.2.2  Sample Size Determination 
Statistical advice was sought and revealed that it was not required to specify a sample size 
for this part of the study because it was considered as an audit. Therefore, all the patients 
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who received dental treatment in the sedation unit at the LDI during the period of 2006-
2011 who were eligible for the study were included. 
 
2.3  PROSPECTIVE PHASE  
In this phase of the study, the outcomes of treatment under IHS were obtained on a 
prospective basis as well as the p-IOSN score. Therefore, a parent’s information sheet 
(Appendix 6) explaining the current study was posted to all paediatric patients attending the 
sedation unit at the LDI for assessment along with their appointment letter. On the day of 
their appointment, potential participants and their parents were introduced to the study by 
the CI in the sedation unit (Figure 2.1).  
 
Figure 2.1 Sedation Unit at the Leeds Dental Institute  
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Upon their willingness to participate, the parent or legal guardian was asked to sign a 
consent form (Appendix 7). Similarly, the child patient was assented to participate; it was a 
verbal assent for children under 10 years of age (Appendix 8) and written assent for older 
children (Appendix 9). After that, each child participant was asked to complete an anxiety 
questionnaire. There were two anxiety questionnaires; the FIS (Appendix 10) was used for 
children under 10 years of age and the MCDASf (Appendix 11) for older children. 
According to the score the patients achieved on the anxiety scale, the CI calculated an 
“anxiety score” for each child and transferred this to the data collection sheet (Appendix 
12). The following data were also transferred to the data collection sheet:  
a. Age 
b. Gender 
c. p-IOSN : which is the sum of:  
• Anxiety score  
• Treatment complexity score 
• Medical status score 
The means by which p-IOSN was calculated will be discussed in the following section 
(2.3.1).  
Upon completion of the course of the treatment in the sedation unit, the CI reviewed the 
participants’ clinical records to note the treatment outcome which was then entered into the 
data collection sheet.  The treatment outcome was recorded as discussed above in section 
2.2.1. 
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Inclusion Criteria 
• All the patients who were assessed for dental treatment under inhalation sedation at 
the LDI during the period of January to June 2013 and agreed to participate. 
• Aged between 5 and 16 years inclusive. 
Exclusion Criteria 
• Patients for whom a decision was made to treat them utilising means other than IHS 
on their initial assessment visit at the sedation unit. 
 
2.3.1  Calculation of p-IOSN Score 
p-IOSN is the paediatric version of the IOSN which the investigators of the current study 
have modified from the IOSN. The IOSN was recently introduced by Coulthard and co-
workers in 2011 (Coulthard et al., 2011). The modification of the IOSN was carried out in 
order for it be suitable for use in paediatric dentistry. The IOSN was designed to be used for 
adult patients as the anxiety scale it utilises is an adult scale and the treatment complexity 
ranking was based on treatment that was not usually performed in the paediatric dentistry 
field (Appendix 13). Therefore the components of IOSN (and then symbolised as p-IOSN 
to emphasise the modifications to fit paediatric dentistry) were modified by the 
investigators as follows: 
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Anxiety 
Due to the wide age range of the study group, the investigators decided to use two anxiety 
scales; the FIS was used for children less than 10 years of age because of its ease of use and 
briefness; with the minimum FIS score being 1 and maximum 5. The patients who had 
minimal anxiety (FIS 1) were scored 1 on the anxiety domain of the p-IOSN. Those who 
had moderate anxiety (FIS 2-3) were scored 2 on the anxiety domain; highly anxious 
patients (FIS 4-5), were scored 3. For older patients the MCDASf was used to evaluate their 
anxiety levels. MCDASf can yield a minimum score of 8 and a maximum of 40. 
Consequently, patients who scored 8-17 on MCDASf were considered as having minimal 
anxiety and scored 1 on the anxiety domain of the p-IOSN. Those who had moderate 
anxiety (MCDASf 18-28) were scored 2 on the anxiety domain of the p-IOSN. Patients 
were given a score of 3 on p-IOSN for the anxiety domain if they scored 29 to 40 on 
MCDASf. It is worth mentioning here that the cut-off points for categorising the level of 
anxiety were determined arbitrarily by the investigators. 
 
Treatment Complexity 
The treatment complexity ranking score proposed by the IOSN authors could not be used in 
paediatric dentistry. Hence, the investigators modified the treatment complexity rank score 
to the one used in the p-IOSN as described in Table 2.1. The score of treatment complexity 
of p-IOSN ranges from 1-4.  
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Table 2.1 Treatment Complexity Rank Score for the Paediatric Version of the 
Indicator of Sedation Need (p-IOSN) 
Rank  Description Score 
Routine Polishing, fluoride application, fissure sealants,  one-surface 
restorations 
1 
Intermediate 2-surface restorations, extraction of 1 primary tooth, one-
quadrant restorative dentistry  
2 
Complex Crown preparation, pulp treatment, extraction of multiple 
primary teeth, multiple-quadrant restorative dentistry, 
extraction of 1 permanent tooth 
3 
High complexity Multiple extractions of permanent teeth, surgical extractions, 
biopsy 
Any treatment considered more complex than above or are  
multiples of the above 
4 
 
Medical Status 
The medical status scoring was adopted from the same ranking score of the IOSN and 
ranged from 1-4. It was based on the ASA class. Patients who were ASA I had a score of 1 
on p-IOSN. Those who were ASA II and/or have a strong gag reflex were given a score of 
2 or 3 depending on the severity of the case. Finally those who were ASA III had a score of 
4. A summary of calculating p-IOSN is presented in Table 2.2. 
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Table 2.2 Summary of  p-IOSN Scoring System 
p-IOSN domain Source Score 
Anxiety  For 5 to 9 years old patients [Facial Image Scale (FIS)]: 
FIS score of 1 is minimal anxiety 1 
FIS score of 2 or 3 is moderate anxiety 2 
FIS score of 4 or 5 is high anxiety 3 
For 10 to 16 years old patients [Faces version of the Modified Child Dental 
Anxiety Scale (MCDASf)]: 
MCDASf  between 8-17 is minimal anxiety 1 
MCDASf  between 18-28 is moderate anxiety 2 
MCDASf  between 29-40 is high anxiety 3 
  
Treatment 
complexity 
Routine 1 
Intermediate 2 
Complex 3 
High Complexity 4 
  
Medical status ASA I 1 
ASA II and/or strong gag reflex (depends on clinical judgment) 2-3 
ASA III 4 
  
Total p-IOSN 
score 
Anxiety score + treatment complexity score + Medical status score 3-11 
Key: 
p-IOSN: Paediatric version of the Indicator of Sedation Need 
ASA classification: American Society of Anaesthesiologists classification of physical health 
ASA I: Healthy  
ASA II: Mild Systemic Disease 
ASA III: Severe Systemic Disease (that does not pose a constant threat to life) 
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2.3.2  Sample Size Determination 
Statistical advice was sought and revealed that because there were no previous studies to 
investigate the IOSN for children then a sample size could not be calculated. It was 
recommended though to have as many participants as possible because the larger the 
sample size, the more chance that their responses would reflect the population.  
 
2.4  ANALYSIS OF DATA  
The collected data were compiled into Excel sheets (Microsoft Excel 2010) and then 
statistical analysis was carried out using the SPSS statistical package for windows version 
19 (SPSS Inc. Illinois). A significance level of α < 0.05 was adopted. 
The Following statistical methods were performed (Harris and Taylor, 2004): 
 One-way Analysis of Variance (ANOVA): a statistical technique used for numerical 
data. It is used to compare the means of two or more samples to see whether they 
come from the same population. 
 Chi-Squared test: used for normally distributed data to measure the difference 
between actual and expected frequencies. 
 Descriptive statistics: Descriptive statistics like means and standard deviations were 
computed using SPSS and Microsoft Excel 2010. 
 Levene’s test: used to test the homogeneity (equality) of variances. P value of more 
than 0.05 indicates that equal variances are assumed whilst p value of less than 0.05 
indicates that equal variances are not assumed. 
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 Post hoc analysis: consists of looking at the data – after the experiment has 
concluded – for patterns that were not specified earlier 
 Tukey's HSD (honestly significant difference) test: is a single-step multiple 
comparison procedure and statistical test. It is used in conjunction with an ANOVA 
to find means that are significantly different from each other. It is a type of post hoc 
tests. 
 Fisher’s exact test: is an accurate test for association between categorical variables. 
It is used also to analyse contingency tables. 
 Kruskal–Wallis one-way analysis of variance by ranks (named after William 
Kruskal and W. Allen Wallis) is a non-parametric method for testing whether samples 
originate from the same distribution. It is used for comparing more than two 
samples that are independent, or not related. 
 Difference in proportion tests: Compare two sample proportions using the 2-sample 
z-test. P-values can be calculated for one- or two-tailed comparisons and are 
compared results to a specified significance level. 
 Independent sample t-test: is used to compare only samples. It tests the probability 
that the samples come from a population with the same mean value. It used for 
normally distributed data sets.  
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3.0 RESULTS 
 
3.1  RETROSPECTIVE PHASE RESULTS 
A total of 465 patient notes were received from the administrative office. The CI reviewed 
all the notes; out of the 465 notes received, 455 of the notes were for patients who were 
treated in the sedation unit at the LDI. Of the 455 patients’ records, 453 met the inclusion 
criteria. One patient was excluded because they were 19 years of age; the other was 
excluded due the fact that the treatment they required at the time of referral was no longer 
indicated when they attended the sedation unit. There were slightly more female patients 
(n= 240) than males (n= 213) with a mean age of about 10.30 (SD = 2.95) years. The 
majority of patients were treated by senior postgraduate paediatric dentistry students; the 
rest were treated by specialist registrars in paediatric dentistry.  Initially, two analyses were 
conducted on the retrospective data, which consisted of a one-way ANOVA focusing upon 
the relationship between patient age and treatment outcome, and a Chi-square analysis 
conducted between patient gender and treatment outcome. 
 
3.1.1  Relationship between Patient Age and Treatment Outcome 
The following table (Table 3.1) summarises the descriptive statistics conducted focusing 
upon patient age on the basis of treatment outcome.  
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Table 3.1 Descriptive Statistics: Age (Years) by Treatment Outcome (Retrospective 
Phase) 
Treatment Outcome N % Mean SD 
Outcome 1 288 63.6 10.428 2.894 
Outcome 2 32 7.1 10.762 2.523 
Outcome 3 72 15.9 9.087 2.835 
Outcome 4 10 2.2 11.857 3.060 
Outcome 5 51 11.2 10.657 3.281 
Total 453 100 10.295 2.953 
Key: 
N: Number 
SD: Standard Deviation 
Outcome 1: treatment completed as planned, Outcome 2: modified treatment completed, Outcome 
3: treatment abandoned in sedation unit and child referred to be treated under general anaesthesia, 
Outcome 4: treatment abandoned in sedation unit and child referred to be treated under local 
anaesthesia, Outcome 5: child failed to return to complete treatment 
 
These results indicated the lowest mean age in cases where the treatment was abandoned 
and the child was referred to be treated under GA, with the highest mean age found in cases 
where treatment was abandoned in the sedation unit and the child was referred to be treated 
under LA. The following box plot (Figure 3.1) was conducted on patient age and indicated 
a mean age of approximately 10 years, with an interquartile ranging from slightly above 8 
to slightly above 13 years. 
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 Figure 3.1 Box Plot: Patient Age in Years (Retrospective Data) 
 
 
Following this, Levene’s test was conducted for the homogeneity of variances. This 
analysis failed to achieve statistical significance, Levene statistic (4, 448) = 1.543, p = 
0.189. This result indicated that the assumption of the homogeneity of variances was not 
violated in this analysis. Next, the one-way ANOVA itself did achieve statistical 
significance, F(4, 448) = 4.375, p = 0.002. This significant result indicated that significant 
mean differences in patient age were present on the basis of treatment outcome. 
A series of post-hoc analyses were conducted using Tukey’s HSD in order to determine 
between which specific treatment outcomes there existed significant differences in patient 
age. In total, three significant pairwise comparisons were indicated. Specifically, the 
following three treatment outcomes: Completed as planned, treatment abandoned in 
sedation unit and child referred to be treated under LA, and child failed to return to 
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complete treatment.  All had significantly higher mean patient ages as compared with 
treatment abandoned and child referred to be treated under GA. 
  
3.1.2  Relationship between Patient Gender and Treatment Outcome 
Following this, Chi-square analyses along with Fisher’s exact test were conducted in order 
to determine whether a significant association existed between patient gender and treatment 
outcome. No significant association was indicated between these two measures, χ2 (4) = 
4.204,  p = 0.383, Fisher’s exact test = 4.210, p = 0.378. Figure 3.2 illustrates the 
distribution of treatment outcome based on patient gender.  
 
 
 
Figure 3.2 Distribution of Treatment Outcome Based on Patient Gender (Retrospective 
Phase) 
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Key: 
Outcome 1: treatment completed as planned, Outcome 2: modified treatment completed, 
Outcome 3: treatment abandoned in sedation unit and child referred to be treated under 
general anaesthesia, Outcome 4: treatment abandoned in sedation unit and child referred to 
be treated under local anaesthesia, Outcome 5: child failed to return to complete treatment 
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3.2  PROSPECTIVE PHASE RESULTS 
During the period of January to June 2013, 42 patients agreed to participate in the study. 
However, two patients were excluded from the study because they were referred to have 
their dental treatment under GA on the day of their assessment at the sedation unit. The 
sample consisted of 40 patients; 16 males and 24 females. The mean age was 9.99 years 
(SD = 3.14). All the patients included in this phase of the study were treated by 
postgraduate students in paediatric dentistry. In the next sections, a series of analyses were 
conducted in order to determine whether significant associations were found between 
treatment outcome and patient age, gender, p-IOSN, anxiety score, treatment complexity, 
and medical status using the prospective data. 
 
3.2.1  Relationship between Patient Age and Treatment Outcome  
The following figure (Figure 3.3) presents a box plot constructed on patient age with 
respect to the prospective data. As shown, this presents a mean age slightly above 9 years, 
with an interquartile ranging from slightly above 7 to slightly above 13 years. 
Figure 3.3 Box Plot: Patient Age in Years (Prospective Phase) 
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In order to determine whether a significant association existed between patient age and 
treatment outcome, a one-way analysis of variance was conducted on these data. While 
substantial differences in patient age were found on the basis of treatment outcome in this 
data set, the ANOVA failed to achieve statistical significance, F(4, 35) = 1.815, p = 0.148. 
This result indicated no significant mean differences in patient age on the basis of treatment 
outcome. Table 3.2 summarises the descriptive statistics conducted focusing upon patient 
age on the basis of treatment outcome. 
 
Table 3.2 Descriptive Statistics: Age (Years) by Treatment Outcome (Prospective 
Phase) 
 
Treatment Outcome N % Mean SD 
Outcome 1 29 72.5 10.25 3.085 
Outcome 2 1 2.5 5.25 0.000 
Outcome 3 5 12.5 8.40 2.670 
Outcome 4 3 7.5 12.86 2.290 
Outcome 5 2 5 8.25 0.330 
Total 40 100 9.99 3.140 
Key: 
N: Number 
SD: Standard Deviation 
Outcome 1: treatment completed as planned, Outcome 2: modified treatment completed, 
Outcome 3: treatment abandoned in sedation unit and child referred to be treated under 
general anaesthesia, Outcome 4: treatment abandoned in sedation unit and child referred to 
be treated under local anaesthesia, Outcome 5: child failed to return to complete treatment 
 
3.2.2  Relationship between Patient Gender and Treatment Outcome 
A Chi-square analysis along with a Fisher’s exact test was conducted in order to determine 
whether a significant association existed between patient gender and treatment outcome. 
These analyses did not indicate any significant association between these two measures, χ2 
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Key: 
Outcome 1: treatment completed as planned, Outcome 2: modified treatment completed, Outcome 
3: treatment abandoned in sedation unit and child referred to be treated under general anaesthesia, 
Outcome 4: treatment abandoned in sedation unit and child referred to be treated under local 
anaesthesia, Outcome 5: child failed to return to complete treatment 
(4) = 3.774,  p = 0.516, Fisher’s exact test = 3.484, p = 0.565. Figure 3.4 demonstrates the 
distribution of treatment outcome based on patient gender. 
 
Figure 3.4 Distribution of Treatment Outcome Based on Patient Gender (Prospective 
Phase)  
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Key: 
Outcome 1: treatment completed as planned, Outcome 2: modified treatment completed, 
Outcome 3: treatment abandoned in sedation unit and child referred to be treated under 
general anaesthesia, Outcome 4: treatment abandoned in sedation unit and child referred to be 
treated under local anaesthesia, Outcome 5: child failed to return to complete treatment; p-
IOSN: Paediatric version of the Indicator of Sedation Need 
3.2.3  Relationship between p-IOSN Score and Treatment Outcome 
In order to determine whether a significant association was present between p-IOSN scores 
and treatment outcome, a Kruskal-Wallis ANOVA was conducted on these data. This non-
parametric ANOVA was selected for this analysis as p-IOSN scores were not continuous. 
This test failed to indicate a significant difference in median p-IOSN scores on the basis of 
treatment outcome, K (4) = 7.050, p = 0.133. Figure 3.5 below shows the distribution of p-
IOSN scores according to treatment outcomes. 
 
Figure 3.5 Distribution of P-IOSN Score Based on Treatment Outcome (Prospective 
Phase)   
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3.2.4  Relationship between Anxiety Level and Treatment Outcome  
An additional Kruskal-Wallis ANOVA was conducted in order to determine whether 
significant median differences in patient anxiety level existed on the basis of treatment 
outcome. This analysis did not indicate any significant differences, K (4) = 4.406, p = 
0.354.  
 
3.2.5  Relationship between Treatment Complexity and Treatment Outcome 
Additionally, the Kruskal-Wallis ANOVA conducted between treatment complexity and 
treatment outcome also failed to indicate any significant differences in treatment 
complexity on the basis of treatment outcome, K (4) = 1.747, p = 0.782. 
 
3.2.6  Relationship between Medical Status and Treatment Outcome  
A Chi-square analysis and Fisher’s exact test were conducted in order to determine whether 
a significant association was present between medical status and treatment outcome. The 
results of these analyses did not indicate any significant association between these two 
measures, χ2 (4) = 8.785,  p = 0.146, Fisher’s exact test = 7.299, p = 0.134. 
 
3.3  DIFFERENCE IN PROPORTIONS TESTS  
Additionally, a series of difference in proportions tests were conducted in order to 
determine whether the percentage of patients who had completed their treatment as planned 
(determined to be 63.6% in the retrospective phase) significantly differed from the same 
proportions of patients in the data collected in the prospective phase. With regard to the 
retrospective phase data, 288 patients completed the treatment as planned out of a total of 
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453. The data obtained in the prospective phase are summarised in the following table 
(Table 3.3). 
 
Table 3.3 Prospective Phase: Patients Completing Treatment as Planned 
 
p-IOSN Score N Completed Treatment N Total % 
4 1 1 100 
5 6 7 85.7 
6 14 21 66.6 
7 8 11 72.7 
Key: 
N: Number 
p-IOSN: Paediatric version of the indicator of sedation need 
 
In order to determine whether any significant differences in these proportions are present, a 
series of four difference in proportions tests were conducted between the data obtained in 
the retrospective phase and these four percentages of patients found to have completed 
treatment on the basis of p-IOSN score in the prospective phase. None of these four 
individual difference in proportions tests or an additional test conducted combining all data 
with respect to the prospective phase was found to achieve statistical significance at the 
0.05 alpha level. These results indicated that none of these individual percentages with 
respect to the prospective phase data significantly differed from the value of 63.6% 
observed in the retrospective phase data. 
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3.4  DIVIDING THE SAMPLE INTO TWO AGE GROUPS 
A decision was made to divide the sample into two groups based on age for the following 
reasons: 
 The analyses in section 3.1.1 (retrospective part) showed that there was a 
statistically significant association between patients’ age and treatment outcome. 
Therefore comparing these two age groups would further explore this association. 
 In the prospective phase of the study, age-specific anxiety scales were used. Hence, 
dividing the sample into two groups would point out whether or not the use of any 
of them was superior to the other. 
 Initially, a series of differences in proportions tests were conducted focusing upon 
differences in treatment outcome on the basis of patient age. For the purposes of these 
analyses, age was dichotomised into the following two categories: less than 10 years of age, 
and 10 years of age or more. First, the following table (Table 3.4) summarises the results of 
the analyses conducted focusing on each of the two data sets individually and comparing 
patient treatment outcome on the basis of age category.  
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Table 3.4 Analyses of Treatment Outcome Based on Age Group 
Treatment Outcome < 10 years ≥ 10 years z 
Retrospective
a
    
Outcome 1 64.1% 63.1% 0.221 
Outcome 2 5.5% 8.6% 1.285 
Outcome 3 19.5% 12.4% 2.068** 
Outcome 4 1.4% 3.0% 1.1.55 
Outcome 5 9.5% 12.9% 1.145 
Prospective
b
    
Outcome 1 63.6% 83.3% 1.388 
Outcome 2 4.5% 0.0% 0.911 
Outcome 3 18.2% 5.6% 1.198 
Outcome 4 4.5% 11.1% 0.790 
Outcome 5 9.1% 0.0% 1.313 
Key: 
Outcome 1: treatment completed as planned, Outcome 2: modified treatment completed, Outcome 
3: treatment abandoned in sedation unit and child referred to be treated under general anaesthesia, 
Outcome 4: treatment abandoned in sedation unit and child referred to be treated under local 
anaesthesia, Outcome 5: child failed to return to complete treatment 
**p<.05 
N: Number  
a
Less than 10 years: N = 220; 10 years or more: N = 233  
b
Less than 10 years: N = 22; 10 years or more: N = 18 
 
In order to determine whether significant differences were present in the proportion of 
patients referred to each type of treatment on the basis of age, a series of difference in 
proportions tests were conducted. 
First, with regard to the retrospective data set, for both age groups, approximately 63%-
64% of patients had treatment completed as planned. Next, among younger patients, 5.5% 
had a modified treatment completed, while among older patients, this figure was slightly 
above 8.5%. Nearly 20% of individuals less than 10 years of age had their treatment 
abandoned and were referred to GA, while this figure was approximately 12.5% among 
older patients. This difference in proportions test was also found to achieve statistical 
significance at the 0.05 level, indicating that younger patients were significantly more 
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likely to have treatment abandoned and be referred to GA as compared with older patients. 
Next, approximately 1.5% of younger patients had treatment abandoned and were referred 
to LA, while 3% of older patients fell into this category. Finally, 9.5% of younger patients 
failed to return to complete treatment, while close to 13% of older patients failed to return. 
Next, with regard to the prospective data set, approximately 63.5% of younger patients had 
treatment completed as planned, while this figure was slightly above 83% with regard to 
older patients. Next, 4.5% of younger patients had a modified treatment completed, while 
no older patients fell within this category. Following this, slightly above 18% of younger 
patients had treatment abandoned and were referred to GA, while this figure was only 
slightly above 5.6% with regard to older patients. Additionally, while 4.5% of younger 
patients had treatment abandoned and were referred to LA, this figure was slightly above 
11% among older patients. Finally, among younger patients, slightly above 9% failed to 
return to complete treatment, while this figure was 0% among older patients. None of the 
difference in proportions tests conducted on the prospective data set was found to achieve 
statistical significance. 
 
Subsequently, an independent-samples t-test was conducted in order to determine whether a 
significant difference in p-IOSN scores existed on the basis of age category. This test was 
not found to achieve statistical significance, indicating no significant mean difference in 
scores on the basis of age group, t(38) = 1.787, p = 0.082. 
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The following table (Table 3.5) summarises the results of the difference in proportions tests 
comparing retrospective and prospective data sets on the basis of age group as well as 
treatment outcome.  
 
Table 3.5 Difference in Proportions Tests: Comparing both Data Sets 
Treatment Outcome Retrospective
a
 Prospective
b
 z 
< 10 years    
Outcome 1 64.1% 63.6% 0.047 
Outcome 2 5.5% 4.5% 0.198 
Outcome 3 19.5% 18.2% 0.147 
Outcome 4 1.4% 4.5% 1.078 
Outcome 5 9.5% 9.1% 0.061 
≥ 10 years    
Outcome 1 63.1% 83.3% 1.726 
Outcome 2 8.6% 0.0% 1.297 
Outcome 3 12.4% 5.6% 0.858 
Outcome 4 3.0% 11.1% 1.782 
Outcome 5 12.9% 0.0% 1.624 
Key: 
Outcome 1: treatment completed as planned, Outcome 2: modified treatment completed, Outcome 
3: treatment abandoned in sedation unit and child referred to be treated under general anaesthesia, 
Outcome 4: treatment abandoned in sedation unit and child referred to be treated under local 
anaesthesia, Outcome 5: child failed to return to complete treatment 
N: Number 
a
Less than 10 years: N = 220; 10 years or more: N = 233  
b
Less than 10 years: N = 22; 10 years or more: N = 18 
 
The first set of analyses conducted focused specifically on patients who were under 10 
years of age. With regard to both data sets, approximately 64% of these patients had 
treatment completed as planned, while approximately 5% had a modified treatment 
completed. Next, 18%-20% of patients had treatment abandoned and were referred to GA. 
Following this, approximately 1.5% of patients in the retrospective data set had treatment 
abandoned and were referred to LA, while 4.5% of patients in the prospective data set fell 
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within this category. Finally, slightly above 9% of patients failed to return to complete 
treatment across both data sets. 
The final set of analyses conducted again compared both of these two data sets, but focused 
specifically on patients who were aged 10 years old or greater. First, slightly above 63% of 
individuals in the retrospective data set had treatment completed as planned, while this 
figure was found to be slightly above 83% in the prospective data set. Next, in the 
retrospective data set, slightly above 8.5% of patients had a modified treatment completed, 
while no patients in the prospective data set fell within this treatment category. While 
approximately 12.5% of patients in the retrospective data set had treatment abandoned and 
were referred to GA, this figure was slightly above 5.5% in the prospective data set. 
Following this, 3% of patients in the retrospective data set had treatment abandoned and 
were referred to LA, while this figure was found to be slightly above 11% in the 
prospective data set. Finally, close to 13% of patients in the retrospective data set failed to 
return to complete treatment, while no patients in the prospective data set fell within this 
treatment category. Among all 10 of these differences in proportions tests, statistical 
significance was not found in any case, indicating no significant differences in these 
proportions. 
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4.0 DISCUSSION 
In this chapter, further discussion of the most important components of the current study 
was carried out. 
4.1  STUDY DESIGN AND METHODOLOGY 
The Indicator of Sedation Need (IOSN) assessment tool was first introduced to the dental 
literature in September 2011 by Coulthard and colleagues (Coulthard et al., 2011). It is a 
novel tool that could be used as: 
 Referral tool; to help clinicians to identify those patients who would benefit from 
sedation for their dental treatment and refer them accordingly, or 
 Health need assessment tool; to help commissioners to recognise the need of a 
certain population for sedation services. 
Subsequently, two other papers were published by the same group of authors to assess the 
use of the IOSN to serve both of the above mentioned purposes (Pretty et al., 2011, 
Goodwin et al., 2012). The introduction of the IOSN has inspired the investigators of the 
present study to bring it to light. 
The IOSN was modified by the investigators of the current study so that it could be used in 
paediatric dentistry as explained previously in section 2.3.1. In the current study, using the 
IOSN as a referral tool was assessed.  The modified version is abbreviated as p-IOSN in 
order to differentiate it from the IOSN and to refer to the paediatric-dentistry-based 
modification. 
The p-IOSN tool is a novel tool which has been developed by the investigators of this study 
and therefore, at this stage it cannot be used to refer patients to the sedation services as it 
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has to be investigated and evaluated first. Therefore, the present study was carried out in 
two phases. The retrospective phase was carried out to assess the treatment outcomes under 
IHS without the use of p-IOSN. The prospective phase aimed to explore the treatment 
outcomes of patients who had already been referred to the sedation unit using p-IOSN 
score. The results of the two phases were compared and contrasted and any effects of p-
IOSN use were identified.      
 
4.1.1  Sample Size  
Following statistical advice by a qualified biostatistician at the Centre of Epidemiology and 
Biostatistics, University of Leeds, the sample size of the current study was determined as 
follows: 
 Retrospective phase: because this part of the study was considered an audit; a 
formal power calculation of the sample size was not indicated.  Therefore, all the 
patients who had received dental treatment in the sedation unit at the LDI during the 
period of 2006-2011 who were eligible for the study were included. The sample size 
determination method carried out for the retrospective phase in the present study 
was similar to methods performed in previous sedation studies that are reported in 
the literature (Bryan, 2002, Ashley et al., 2010). 
 Prospective phase: Since there was no previous published data in the literature, a 
formal power calculation could not be conducted. The biostatistician advised that a 
sample size of at least 20 patients was required to allow useful statistical analysis. 
However, the inclusion of more patients in this phase would improve the quality of 
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the statistical comparisons made between the data of the retrospective and 
prospective phases. This is because the sample size of the retrospective phase was 
relatively large and hence, the larger the sample of the prospective phase, the more 
realistic the results of the statistical analysis would be. 
Although the sample size of the retrospective phase was larger than the sample size studied 
in the prospective phase, statistical analysis was still possible by utilising the difference in 
proportion test. 
 
4.2  ASSESSMENT OF TREATMENT OUTCOMES  
In the present study, 63.3% and 72.5% of the participants in the retrospective phase and 
prospective phase respectively completed their dental treatment as planned under inhalation 
sedation. These figures were noticeably lower than what have been reported previously in 
the literature (Crawford, 1990, Shaw et al., 1996, Bryan, 2002, Foley 2005).  
The proportion of patients for whom the treatment was abandoned in the sedation unit and 
were referred to have it performed under general anaesthesia was 15.9% and 12.5% in the 
retrospective and prospective phases respectively. This was in accordance with the studies 
by Carwford (1990) and Shaw et al (1996). However, these figures were substantially 
larger than the work performed by Bryan (2002) where only 2.4% of the child patients were 
referred to have their treatment carried out under general anaesthesia.       
It is important to note here that these studies were conducted using different methodologies 
than the one carried out in the present study and the nature of treatment provided also 
varied widely. The study by Bryan (2002) was conducted in a similar way as the present 
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study in that all the records of children who were referred to have various dental procedures 
under IHS were evaluated and possible treatment outcomes were considered. However, all 
the analyses were performed retrospectively which might be disadvantageous as the 
enrollment of participants is based on treatment records of which, some might be 
insufficient or lost. In the present study, the information yielded by the prospective phase 
would have compensated for that potential unwanted effect caused by data analysis of the 
retrospective phase alone. In both Carwford (1990) and Shaw et al (1996) studies, only the 
patients who were referred to have extractions or minor surgical procedures were included 
which might cause a form of selection bias. Moreover, in both studies the use of IHS was 
assessed as an alternative to GA; other possible outcomes of the treatment (e.g. modified 
treatment completed) could not be assessed. 
 
4.3  EVALUATION OF CHILDREN AGE 
4.3.1  The Mean Age of Children  
The mean age of the patients included in the retrospective phase of this study was 10.3 (SD 
= 2.95) years; prospective phase, 9.99 (SD = 3.14) years. These figures were comparable to 
the mean age of participants in the study by Soldani and co-workers which compared 
different inhalation sedation agents for dental treatment of children where the mean age 
was 10.6 years (Soldani et al., 2010).  
On the other hand, the mean age of patients included in the present study was considerably 
more than the mean age found by Bryan (2002) which was 7.2 years and also contrasted 
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with the study by Ashley et al. who reported on the sedation of children in the primary care 
sector in the UK; the mean age was 8.5 years (Bryan, 2002, Ashley et al., 2010). 
In contrast, the child patients in the present study were younger than some of the other 
previous studies. In a number of studies conducted to compare midazolam (delivered by 
various routes) to nitrous oxide sedation for paediatric dental care the mean age of patients 
ranged from 12.5 years to 13.2 years (Wilson et al., 2002a, Wilson et al., 2003, Wilson et 
al., 2007). Another study comparing nitrous oxide to propofol IV sedation for the dental 
treatment of anxious children revealed that the mean age of patients treated under nitrous 
oxide sedation was 11 years (Alexopoulos et al., 2007).  
 
4.3.2  Association between Child Age and Treatment Outcome 
In the present study there was a statistically significant association between patient age and 
that “treatment is abandoned in the sedation unit and child referred to have treatment under 
GA” as a treatment outcome when the retrospective data were analysed. This association 
failed to achieve statistical significance when the prospective data were analysed. This 
could be attributed to the relatively small sample size assessed in the prospective phase. 
When that significant association was further explored, it was found that the patients who 
were younger than 10 years were more likely to require general anaesthesia for their dental 
treatment. This is in agreement with previous studies which reported that children with 
mean age ranging from about 3 years to slightly above 7 years were referred to have their 
dental treatment under general anaesthesia (Eidelman et al., 2000, Harrison and Nutting, 
2000, Camilleri et al., 2004). Although the mean age of patients who completed the 
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treatment successfully under IHS in the study conducted by Bryan (2002) was substantially 
lower than the mean age of the patients that participated in the current study, it also 
suggested that children younger than 5 years of age were more likely to require general 
anaesthesia for their dental treatment.  
In the present study, no significant association was found between patient’s age and any 
treatment outcome other than outcome 3 (i.e. treatment abandoned in sedation unit and 
child was referred to have their treatment under GA). This is expected as inhalation 
sedation is the recommended route for conscious sedation for paediatric dentistry in 
addition to its numerous advantages (Hosey, 2002).  
 
4.4  EVALUATION OF PATIENT GENDER 
4.4.1  The Male to Female Ratio of Patients Referred to Sedation 
Girls represented the majority of the sample included in both phases of the current study. 
This compares favourably with the findings of Soldani and co-workers (Soldani et al., 
2010) whilst there were more males in the cohorts studied by other researchers (Bryan, 
2002, Foley, 2005, Ashley et al., 2010, Lourenço-Matharu and Roberts, 2010).  
The literature is equivocal regarding the association between gender and dental anxiety. 
Some studies have found no gender differences in children’s and adolescent’s dental fear 
(Locker et al., 2001, Majstorovic et al., 2003, Muris et al., 2005). However, several studies 
reported that girls were more dentally anxious than boys (Majstorovic and Veerkamp, 2004, 
Klingberg and Broberg, 2007). 
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4.4.2  The Association of Patient Gender and Treatment Outcome  
It is interesting to note that in the present study, there was no significant association 
between gender and any particular treatment outcome. This contrasts with the results of 
Foley’s study on the perception of IHS where male participants less than 10 years of age 
were found to cope better with IHS than female patients of the same age (Foley, 2005). 
Many studies in the literature however lacked the investigation of gender differences on the 
basis of treatment outcome. For example, the study by Bryan has commented on the 
percentage of males and females included in the study population which was 51.2% and 
48.8% respectively, but failed to relate any gender differences to treatment outcomes 
(Bryan, 2002). Similarily, the female to male ratio was 3:2 in Soldani and co-workers 
study, but there was no mention about gender differences based on treatment outcomes 
(Soldani et al., 2011). 
 
4.5  ASSESSMENT OF THE p-IOSN TOOL  
As discussed previously, the p-IOSN is an assessment tool that has been developed by the 
investigators of the current study from the IOSN which was introduced as a novel 
assessment tool that could be utilised to predict the sedation need of adult dental patients 
(Coulthard et al., 2011, Pretty et al., 2011, Goodwin et al., 2012). For that reason, careful 
assessment of the suitability of this newly devolved tool (p-IOSN) to serve its meant 
purpose was crucial.  
Similar to the IOSN, the p-IOSN tool is composed of three components: anxiety score, 
medical status and treatment complexity. Statistical analysis was performed to investigate 
whether or not there was an association between the score of any component and any 
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particular treatment outcome. The analysis resulted in that neither anxiety score, medical 
status nor treatment complexity score was associated with any specific outcome; which 
indicates that all of these components are equally important in assessing the need for 
sedation. This is expected as these three components embrace the indications for dental 
sedation in general. According to the EAPD guidelines on sedation in paediatric dentistry, 
sedation is indicated for the dental treatment of the children who have low coping ability, 
dental anxiety, or disruptive behaviour as well as those who require extensive dental 
treatment (Hallonsten et al., 2003). Moreover, it is reported in the literature that inhalation 
sedation with nitrous oxide/oxygen is indicated for dentally anxious patients, some medical 
conditions (especially for which GA is contra-indicated) and for extensive or unpleasant 
dental procedures  (Hosey, 2002, Paterson and Tahmassebi, 2003). 
 
4.6  EVALUATION OF THE ANXIETY SCALES 
In the current study, the FIS and MCDASf were used to assess the level of dental anxiety of 
participating children and then determine the score of the anxiety component of the p-
IOSN. The purpose of choosing two and not only one anxiety scale was due to the 
relatively wide age range of the patients included in the study; hence, age-specific anxiety 
scales were used. The FIS is a valid anxiety scale that can be employed to evaluate the 
anxiety of children of any age from 3 to 18 years (Buchanan and Niven, 2002). However, 
this scale cannot indicate the details of the potential sources of the anxiety. Therefore, the 
MCDASf was also used as it consists of eight questions that tackle different aspects of 
dentistry which could be potential causes of dental anxiety. The MCDASf is a valid and 
reliable measure of dental anxiety in children aged 8-12 years (Howard and Freeman, 
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2007). Therefore, both FIS and MCDASf were used so that the anxiety of the 5-16 years old 
children included in the present study could be evaluated. 
The FIS was used to assess the anxiety level in 5-9 year old children enrolled in the present 
study, while the MCDASf was used for children who were 10-16 years. Statistical analysis 
revealed that differences between treatment outcomes yielded by the two age groups failed 
to achieve statistical significance. This would imply that both FIS and MCDASf were 
equally effective in measuring the anxiety of children in the respective age groups. This is 
expected as both scales have been previously validated. 
Although both FIS and MCDASf have been validated by previous research (Buchanan and 
Niven, 2002, Howard and Freeman, 2007), a recent paper by Guinot and colleagues have 
argued that because children’s anxiety is of a multi-dimensional nature, more studies are 
needed to determine the reliability and validity of the measures used to assess dental 
anxiety in children. The authors further explained that the low level of correlation among 
the different methods of assessing anxiety in children seems logical given the 
physiological, cognitive and motor responses that manifest in different ways in each 
individual (Guinot et al., 2011). In another study assessing pain-related behaviour in 
children over two dental appointments, the dental subscale of the children’s fear survey 
schedule (CFSS-DS) was used to assess the level of dental anxiety of the patients. One of 
the girls who participated in the study mentioned “Look,” pointing at face #2 “I choose this 
one; and you know why?” The dentist shook his head. “Because last time I picked this one 
(pointing at #4) and next time I will choose this one (pointing #6)” (Hembrecht et al., 
2013). This shows that children may not have the appropriate cognitive level to use the 
anxiety scales correctly.  
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There was some debate that completing a dental anxiety questionnaire prior to a dental 
procedure would increase anxiety. However, a paper by Carlsen and co-workers had 
disproved this belief. In their study, they included 195 children aged from 7-16 years 
attending four community dental clinics to determine whether pre-treatment enquiries about 
anxiety and pain influenced their subsequent reports of pain and anxiety immediately after 
treatment. Contrary to some expectations, answering questions about dental anxiety did not 
cause deleterious effects on patients. In fact, completing these questions appeared to be 
beneficial in reducing self-reported pain experience. The authors attributed this effect to the 
fact that encouraging children to consider how anxious they were about certain dental 
procedure and the prospect of discomfort enabled them to be prepared psychologically for 
their dental treatment (Carlsen et al., 1993). A randomised controlled trial had been 
conducted on adults to assess the same issue, and had comparably concluded that the 
completion of a brief dental anxiety survey before seeing the dentist had no significant 
effect on their anxiety levels post-operatively (Humphris et al., 2006). 
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4.7  ASSESSING THE NULL HYPOTHESIS  
The treatment was completed as planned in the retrospective phase in 63.3% of the cases 
compared with 72.5% in the prospective phase. The difference did not achieve statistical 
significance. Further analysis of treatment completion rate in the prospective phase 
revealed that treatment completed as planned in 100% of the patients who scored 4 on the 
p-IOSN, 85.7% of the patients who scored 5 on the p-IOSN, 66.6% of the patients who 
scored 6 on the p-IOSN and 72.7% of the patients who scored 7 on the p-IOSN. The 
difference between all of these percentages and the completion rate with regard to the 
retrospective phase (63.3%) was not statistically significant. Therefore, the null hypothesis 
which stated that “There is no significant difference between the completion rate of dental 
treatment under inhalation sedation with or without the use of p-IOSN of any score” was 
accepted.  
It is important to note that at the LDI, the decision to refer patients to the sedation unit for 
dental treatment is made by consultants in paediatric dentistry; or at least, that decision is 
supported and confirmed by the consultants. All the patients included in the present study 
were referred to the sedation unit in the same manner. By accepting the null hypothesis, it 
could be suggested that the use of p-IOSN as a referral tool – which was found to be 
comparable to experienced consultant opinion – might be beneficial in primary care centres 
to help less-experienced clinicians in decision making.   
Fifty percent of the patients in the prospective phase (n=20) scored p-IOSN of 6, 27.5% 
scored p-IOSN of 7, 20% scored p-IOSN of 5, and only 2.5% scored p-IOSN of 4. There 
was no significant association between any of the treatment outcomes and any particular p-
IOSN score. Based on that, it could be proposed that a p-IOSN score of less than 5 would 
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mean minimal need for sedation, a p-IOSN score of 5 would mean moderate need for 
sedation and a p-IOSN of greater than 5 would mean high need for sedation. This is slightly 
different than what the authors of the IOSN suggested, where an IOSN score of 3-4 was 
minimal need for sedation, an IOSN score of 5-6 was moderate need for sedation, 7-9 was 
high need for sedation and an IOSN of 10-11 was very high need for sedation (Coulthard et 
al., 2011). Obviously, the p-IOSN descriptors mentioned here should be considered as 
suggestions only rather than guidelines until further research on the p-IOSN tool emerges. 
 
4.8  SUGGESTIONS FOR FUTURE RESEARCH 
The p-IOSN is a new tool that is still in the investigational stages. Hence, further research is 
needed prior to adopting its use in the clinical field. The results yielded by the current study 
could form the basis of future research. Below, suggestions for further investigations on p-
IOSN are discussed. 
 
4.8.1  Sample Size 
Although the sample size studied in the prospective phase using the p-IOSN was relatively 
small, statistical analysis was still possible and revealed beneficial results. However, a 
larger sample size would allow more reasonable comparisons and would be more 
representative of the studied population. 
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4.8.2  Assessing the Behaviour Score 
Many studies in the literature have scored behaviour of children undergoing sedation for 
dental treatment. These studies reported that the behaviour of the majority of the patients 
who completed treatment successfully was excellent or very good (Foley, 2005, Lourenço-
Matharu and Roberts, 2010). This means that there was a small proportion of patients who 
had completed the proposed treatment successfully but with lower behaviour scores. 
In the present study, the treatment completion rate ranged from 63.6% to 72.5%. 
Nevertheless, the behaviour score was not assessed although Frankl and Houpt behaviour 
rating scores were available in treatment records. The reason for not evaluating this piece of 
information in the present study was that scoring the behaviour of a child could vary widely 
among clinicians and could differ across different treatment visits and different procedures 
(e.g. restoration vs extraction). In Soldani et al (2009) study, there was no agreement 
between observers’ Frankl scores given to child participants. Therefore, assessing the 
behaviour score by a number of calibrated assessors along with the outcome of dental 
treatment under sedation should be considered in future research and investigations using 
the p-IOSN.  
 
4.8.3  Experience Level of the Dentist 
One of the objectives of Bryan’s study (2002) about the success of inhalation sedation for 
dental care was to relate the outcomes of treatment to the experience of the operating 
dentist. The results showed that there was no difference in the number of failures in relation 
to the experience of the operator (Bryan, 2002). In the present study, such association was 
not explored. The majority of patients were treated by postgraduate paediatric dentistry 
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students while very few patients included in the retrospective phase were treated by a 
specialist registrar in paediatric dentistry who had a significantly longer training period than 
the postgraduate students. There was no significant difference in treatment outcomes found 
when retrospective and prospective phases of the study were compared. This might imply 
that the experience level of the treating dentist did not affect treatment outcome; yet, this 
should be considered in future research especially when use of inhalation sedation is being 
investigated, where the psychological reassurance ability of the dentist is important 
(Paterson and Tahmassebi, 2003). Another interesting point to consider is the experience 
level of the referring dentist. In the LDI where the current study was conducted, the 
decision to refer patients to the sedation unit was confirmed and supported by consultants in 
paediatric dentistry. This is not the case in every dental clinic. Therefore, investigating the 
relation between experience of the referring dentist and treatment outcome in future 
research would add valuable information. 
 
4.8.4  Anxiety Scales 
In the present study the FIS and MCDASf were chosen among other anxiety scales for 
several reasons as discussed previously (section 4.6). There are other valid anxiety scales, 
however, that have been used previously in dental research (Venham et al., 1977, de 
Menezes Abreu et al., 2011, Hembrecht et al., 2013). So, assessing the incorporation of 
other anxiety scales in the p-IOSN tool would be an area of future research. For example, 
Venham picture scale could potentially be used as it is easy to apply, understandable for a 
wide age range of children and provides more information about the dental situation than 
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the FIS. Moreover the use of CFSS-DS which is consisted of 15 items is precise, allows 
measurement of trait anxiety and provides very useful data (Guinot et al., 2011).   
 
4.8.5  Other Types of Sedation 
The present study only evaluated the use of p-IOSN for children undergoing inhalation 
sedation with nitrous oxide and oxygen mixture. In the literature though, other inhalation 
sedative agents (Soldani et al., 2010) as well as other routes of conscious sedation have 
shown promising results (Wilson et al., 2002a, Wilson et al., 2003, Wilson et al., 2006, 
Alexopoulos et al., 2007, Gilchrist et al., 2007, Wilson et al., 2007). Although inhalation 
has been advocated as the recommended route for conscious sedation for paediatric 
dentistry (Hosey, 2002), the authors of a review paper were not able to reach any definitive 
conclusion on which was the most effective sedative agent or route of sedation used for the 
dental care of anxious children due to issues with the quality and validity of published 
studies (Matharu and Ashley, 2007). Therefore, the use of p-IOSN to assess the need for 
other sedation methods than the one utilised in the current study would shed light on other 
useful information. 
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5.0 CONCLUSIONS 
Based on the results of the current study on the treatment outcomes of dental treatment 
under inhalation sedation utilising p-IOSN tool, it can be concluded that: 
 Children under 10 years of age are more likely to require general anaesthesia to 
facilitate their dental treatment. 
 Utilising p-IOSN may be beneficial in predicting child patients who would benefit 
from sedation for their dental treatment. 
 Caution is to be considered when using the p-IOSN assessment tool as further 
research and investigation should be carried out prior to its formal use in the clinical 
field. 
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